1 | M-M-RVAXPRO | 1件: Measles virus vaccine live attenuated Measles virus vaccine live attenuated | - | - | - | 1件: 107 107 |
2 | M071754 | - | - | - | - | 1件: 145 145 |
3 | M2591 25 mg QD | - | - | - | - | 1件: 46 46 |
4 | M281 | - | - | - | - | 5件: 11 11, 46, 49, 53, 61 |
5 | M281 Injection | - | - | - | - | 1件: 11 11 |
6 | M2951 | - | - | - | - | 3件: 13 13, 46, 49 |
7 | M2951 (Other Name: Evobrutinib) | 1件: Evobrutinib Evobrutinib | - | - | - | 1件: 49 49 |
8 | M2951 50 mg BID | - | - | - | - | 1件: 46 46 |
9 | M2951 75 mg QD | - | - | - | - | 1件: 46 46 |
10 | M5049 | - | - | - | - | 1件: 49 49 |
11 | M5049 high dose | - | - | - | - | 1件: 49 49 |
12 | M5049 low dose | - | - | - | - | 1件: 49 49 |
13 | M5049 medium dose | - | - | - | - | 1件: 49 49 |
14 | M923 | - | - | - | - | 1件: 46 46 |
15 | MA09-hRPE | - | - | - | - | 1件: 301 301 |
16 | MABCAMPATH | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 2件: 13 13, 60 |
17 | MABCAMPATH 10 mg/ml concentrado para solución para perfusión | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
18 | MabCampath ® | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
19 | MabCampath-1h | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
20 | MabCampath® | 1件: Alemtuzumab Alemtuzumab | 1件: D02802
D02802
| 1件: CD52 CD52 💬 | - | 1件: 13 13 |
21 | MabionCD20 | - | - | - | - | 1件: 46 46 |
22 | MabionCD20 (candidate biosimilar to rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
23 | MABp1 (Bermekimab) | 1件: Bermekimab Bermekimab | 1件: D11253
D11253
| 1件: IL1A IL1A 💬 | 21件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 51 51 |
24 | MabThera | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 22件: 11 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 |
25 | MabThera (Rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 4件: 13 13, 46, 49, 53 |
26 | MABTHERA - 1 FIALA 500 MG 50 ML | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 14 14, 53 |
27 | MABTHERA - 2 FIALE 100 MG 10 ML | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 19 19, 65 |
28 | MabThera 100 mg concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 222 222 |
29 | MabThera 100mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
30 | MabThera 500 | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 271 271 |
31 | MabThera 500 mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
32 | MabThera 500 mg (10 mg/ml) concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
33 | MabThera 500 mg (10mg/ml) | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
34 | MABTHERA 500 mg concentrado para solución para perfusión | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
35 | MabThera 500 mg concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 222 |
36 | MabThera 500 mg Konzentrat zur Herstellung einer Infusionslösung | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
37 | MabThera 500mg | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
38 | Mabthera Infusion | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 83 83 |
39 | MabThera infusions | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
40 | Mabthera or biosimilar Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 61 61 |
41 | Mabthera or biosimilar rituximab product | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 |
42 | MABTHERA*EV 1FL 50ML 500MG | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 2件: 46 46, 222 |
43 | MabThera/Rituxan | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
44 | Mabthera® | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 6件: 13 13, 35, 43, 44, 46, 93 |
45 | MabThera® (rituximab) | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
46 | MabThera® 100MG | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 43 43 |
47 | MabThera® 500MG | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 43 43 |
48 | MabThera®, 100 mg Concentrado para solución para perfusión | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
49 | MabThera®, 100 mg concentrate for solution for infusion | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 |
50 | Mabthéra | - | - | - | - | 2件: 35 35, 162 |
51 | Macimorelin | 1件: Macimorelin Macimorelin | 1件: D10563
D10563
| 1件: GHSR GHSR 💬 | 3件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 78 78 |
52 | MACIMORELIN ACETATE | 2件: Acetate Acetate, Macimorelin | 1件: D10563
D10563
| 1件: GHSR GHSR 💬 | 3件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 78 78 |
53 | Macimorelin Consilient Health | 1件: Macimorelin Macimorelin | 1件: D10563
D10563
| 1件: GHSR GHSR 💬 | 3件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 78 78 |
54 | Macimorelina | - | - | - | - | 1件: 78 78 |
55 | Macitentan | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 85, 86, 88, 210 |
56 | Macitentan (ACT-064992) | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
57 | Macitentan 10 mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 51 51, 86, 88 |
58 | Macitentan 10 mg tablet, once daily. | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
59 | Macitentan 10mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 51 51, 88 |
60 | Macitentan 3 mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
61 | Macitentan 37.5 mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
62 | Macitentan 3mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 |
63 | Macitentan 75 mg | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
64 | MACITENTAN COMPRESSE | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 |
65 | Macitentan Group | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
66 | MACITENTAN TABLETS | 1件: Macitentan Macitentan | 1件: D10135
D10135
| 2件: EDNRA EDNRA, EDNRB 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 88 |
67 | Macrilen | 1件: Macimorelin Macimorelin | 1件: D10563
D10563
| 1件: GHSR GHSR 💬 | 3件: Growth hormone synthesis, secretion and action Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 78 78 |
68 | Macroduct sweat stimulator | - | - | - | - | 1件: 299 299 |
69 | Macrogol | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 1件: 299 299 |
70 | Macrogol 4000 | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 1件: 299 299 |
71 | Madeos | - | - | - | - | 1件: 301 301 |
72 | Madopar | - | - | - | - | 1件: 6 6 |
73 | Madopar 125 mg T, tablets | - | - | - | - | 1件: 6 6 |
74 | Madopar 125 mg, orodispersible tablet | - | - | - | - | 1件: 6 6 |
75 | Madopar 200+50 mg | - | - | - | - | 1件: 6 6 |
76 | Madopar LT | - | - | - | - | 1件: 6 6 |
77 | Madopar monotherapy | - | - | - | - | 1件: 6 6 |
78 | Madopar Tab. 125 or Perkin Tab. 25-100mg | - | - | - | - | 1件: 6 6 |
79 | Madopar® 125 | - | - | - | - | 1件: 6 6 |
80 | Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride) | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
81 | Madopar® 250 | - | - | - | - | 1件: 6 6 |
82 | Madopar® HBS | - | - | - | - | 1件: 6 6 |
83 | Madopar® HBS 125 | - | - | - | - | 1件: 6 6 |
84 | MAG-DHA | - | - | - | - | 1件: 299 299 |
85 | Magnesiocard 2.5mmol | - | - | - | - | 1件: 298 298 |
86 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 19件: 3 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298 |
87 | Magnesium aspartate | 2件: Magnesium Magnesium, Magnesium aspartate | 1件: D02026
D02026
| - | - | 1件: 298 298 |
88 | MAGNESIUM ASPARTATE HYDROCHLORIDE | 3件: Magnesium Magnesium, Magnesium aspartate, Magnesium aspartate hydrochloride | 1件: D02026
D02026
| - | - | 1件: 298 298 |
89 | Magnesium citrate | 2件: Magnesium Magnesium, Magnesium citrate | 1件: D03265
D03265
| - | - | 1件: 97 97 |
90 | Magnesium gluconate | 1件: Magnesium gluconate Magnesium gluconate | 1件: D04835
D04835
| - | - | 2件: 296 296, 297 |
91 | Magnesium hydroxide | 3件: Hydroxide ion Hydroxide ion, Magnesium, Magnesium hydroxide | 1件: D00731
D00731
| - | - | 1件: 284 284 |
92 | Magnesium oxide | 2件: Magnesium Magnesium, Magnesium oxide | 1件: D01167
D01167
| - | - | 3件: 6 6, 166, 291 |
93 | Magnesium sulfate | 3件: Magnesium gluconate Magnesium gluconate, Magnesium sulfate, Sulfate ion | 2件: D01108
D01108
,
D04835
| - | - | 3件: 11 11, 296, 297 |
94 | Magnesium with ropivacaine | 2件: Magnesium Magnesium, Ropivacaine | 2件: D04048
D04048
,
D08490
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 70 70 |
95 | Magnetic Resonance Enterography (MRE) | - | - | - | - | 1件: 96 96 |
96 | Magnetic Resonance Imaging | - | - | - | - | 7件: 6 6, 13, 19, 22, 34, 205, 299 |
97 | Magnetic Resonance Imaging (MRI) | - | - | - | - | 1件: 46 46 |
98 | Magnetic resonance imaging (MRI) with gadolinium enhancement | 1件: Gadolinium Gadolinium | - | - | - | 1件: 58 58 |
99 | Magnetic resonance imaging (MRI) without gadolinium enhancement | 1件: Gadolinium Gadolinium | - | - | - | 1件: 58 58 |
100 | Magnetic resonance imaging of the brain | - | - | - | - | 1件: 78 78 |
101 | Maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: D02329
D02329
| - | - | 4件: 6 6, 13, 96, 97 |
102 | Maltodextrin fiber supplement | 1件: Maltodextrin Maltodextrin | 1件: D02329
D02329
| - | - | 1件: 13 13 |
103 | Maltose | 1件: Maltose Maltose | 1件: D00044
D00044
| - | - | 2件: 96 96, 97 |
104 | Management of therapy complications | - | - | - | - | 2件: 28 28, 60 |
105 | Mangafodipir | 1件: Mangafodipir Mangafodipir | 1件: D08262
D08262
| - | - | 2件: 13 13, 58 |
106 | Mangafodipir (Teslascan) | 1件: Mangafodipir Mangafodipir | 1件: D08262
D08262
| - | - | 1件: 13 13 |
107 | Mango | 1件: Mango Mango | - | - | - | 2件: 96 96, 97 |
108 | Mango polyphenolics | 1件: Mango Mango | - | - | - | 2件: 96 96, 97 |
109 | Mannite | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
110 | Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 7件: 6 6, 13, 28, 60, 96, 113, 299 |
111 | Mannitol + pulmozyme | 2件: Dornase alfa Dornase alfa, Mannitol | 2件: D00062
D00062
,
D03896
| - | - | 1件: 299 299 |
112 | Mannitol inhalation powder | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 1件: 299 299 |
113 | MANNITOLO 18% | - | - | - | - | 1件: 2 2 |
114 | MANNITOLO 18% LDB | - | - | - | - | 1件: 2 2 |
115 | Mannose | 1件: Mannose Mannose | - | - | - | 2件: 13 13, 256 |
116 | MANTADAN*20CPR 100MG | - | - | - | - | 1件: 13 13 |
117 | MANTADIX | - | - | - | - | 1件: 6 6 |
118 | Manual therapy | - | - | - | - | 1件: 70 70 |
119 | Manual toothbrush | - | - | - | - | 1件: 51 51 |
120 | Manual toothbrush and water flosser (Philips Sonicare AirFloss) | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 51 51 |
121 | Manufacturerd by Cambridge Therapeutic Antibody Centre, Burroughs Wellcome, Glaxo Wellcome) | - | - | - | - | 1件: 46 46 |
122 | Manuka honey sinus rinse | 1件: Honey Honey | 1件: D06776
D06776
| - | - | 1件: 299 299 |
123 | Maralixibat | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
124 | Maralixibat (formely SHP625 or LUM001) | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
125 | Maralixibat (formerly SHP625 or LUM001) | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 1件: 338 338 |
126 | Maralixibat (in precedenza SHP625 o LUM001) | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 1件: 338 338 |
127 | MARALIXIBAT CHLORIDE | 2件: Chloride ion Chloride ion, Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 3件: 296 296, 297, 338 |
128 | Maralixibat cloruro | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 2件: 296 296, 338 |
129 | Maraviroc | 1件: Maraviroc Maraviroc | 1件: D06670
D06670
| 1件: CCR5 CCR5 💬 | 9件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Toxoplasmosis, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 84 |
130 | Mare´s milk | - | - | - | - | 2件: 96 96, 97 |
131 | Marijuana | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 13 13 |
132 | Marketed plasma-derived VWF/FVIII concentrate | - | - | - | - | 1件: 288 288 |
133 | Marrow graft transplantation | - | - | - | - | 1件: 326 326 |
134 | MARS | - | - | - | - | 1件: 6 6 |
135 | Masitinb mesylate | - | - | - | - | 1件: 13 13 |
136 | MASITINIB | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
137 | Masitinib (3.0) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
138 | Masitinib (4.5) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
139 | Masitinib (6.0) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
140 | Masitinib (AB1010) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 46 46 |
141 | Masitinib 100 mg Tablets | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
142 | Masitinib 100mg | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 5 |
143 | Masitinib 200 mg Tablets | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
144 | Masitinib 200mg | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 5 |
145 | Masitinib 3 mg | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 46 46 |
146 | Masitinib 6.0 mg | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 46 46 |
147 | Masitinib mesilate | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 13 |
148 | MASITINIB MESYLATE | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
149 | MASP-2 antibody | 1件: Narsoplimab Narsoplimab | 1件: D11531
D11531
| 1件: MASP2 MASP2 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 3件: 64 64, 66, 109 |
150 | MASP-2 Antibody, OMS00620646, OMS620646 | 1件: Narsoplimab Narsoplimab | 1件: D11531
D11531
| 1件: MASP2 MASP2 💬 | 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 66 66 |
151 | Massage with a spiky ball | - | - | - | - | 1件: 6 6 |
152 | MasterGraft Granules | - | - | - | - | 1件: 70 70 |
153 | Mastinib | - | - | - | - | 1件: 13 13 |
154 | Matched isoglycemic clamp | - | - | - | - | 1件: 299 299 |
155 | Matched Unrelated Donor Hematopoietic Stem Cell Transplant | - | - | - | - | 1件: 60 60 |
156 | Maternal Hyperoxygenation | - | - | - | - | 1件: 211 211 |
157 | Mathéra | - | - | - | - | 2件: 35 35, 162 |
158 | MATRICARIA FLOWER | 1件: Chamomile Chamomile | 1件: D09212
D09212
| - | - | 1件: 97 97 |
159 | MATRICARIA RECUTITA L. FLOS | - | - | - | - | 1件: 97 97 |
160 | Matyrapone | - | - | - | - | 1件: 75 75 |
161 | MAVACAMTEN | 1件: Mavacamten Mavacamten | 1件: D12265
D12265
| 1件: MYH7 MYH7 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Thyroid hormone signaling pathway, Viral myocarditis, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
162 | MAVENCLAD | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
163 | MAVENCLAD - 10 MG - COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
164 | MAVENCLAD 10 mg tablets | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
165 | Mavenclad tabletter 10 mg | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
166 | Mavenclad® | 1件: Cladribine Cladribine | 1件: D01370
D01370
| 1件: RRM1 RRM1 💬 | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism 💬 | 1件: 13 13 |
167 | Mavoglurant | 1件: Mavoglurant Mavoglurant | - | - | - | 2件: 6 6, 206 |
168 | Mavorixafor | - | - | - | - | 1件: 65 65 |
169 | MAVRILIMUMAB | 1件: Mavrilimumab Mavrilimumab | 1件: D09930
D09930
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 2件: 41 41, 46 |
170 | Mavrilimumab 10 mg | 1件: Mavrilimumab Mavrilimumab | 1件: D09930
D09930
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 |
171 | Mavrilimumab 100 mg | 1件: Mavrilimumab Mavrilimumab | 1件: D09930
D09930
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 |
172 | Mavrilimumab 150 mg | 1件: Mavrilimumab Mavrilimumab | 1件: D09930
D09930
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 |
173 | Mavrilimumab 30 mg | 1件: Mavrilimumab Mavrilimumab | 1件: D09930
D09930
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 |
174 | Mavrilimumab 50 mg | 1件: Mavrilimumab Mavrilimumab | 1件: D09930
D09930
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 46 46 |
175 | Maxidex | - | - | - | - | 1件: 53 53 |
176 | Maximal oral 5ASA | - | - | - | - | 1件: 97 97 |
177 | MAXOMAT ®, biosynthetic growth hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 195 195 |
178 | Maxtrex | - | - | - | - | 1件: 46 46 |
179 | Mayo Interactive Breath Hold Monitor | 1件: Methamidophos Methamidophos | - | - | - | 2件: 298 298, 300 |
180 | Mayzent | 1件: Siponimod Siponimod | 1件: D11460
D11460
| 2件: S1PR1 S1PR1, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
181 | Mayzent 0,25 mg Filmtabletten | 1件: Siponimod Siponimod | 1件: D11460
D11460
| 2件: S1PR1 S1PR1, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
182 | Mayzent 0.25 mg fi | 1件: Siponimod Siponimod | 1件: D11460
D11460
| 2件: S1PR1 S1PR1, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
183 | Mayzent 2 mg film-coated tablets | 1件: Siponimod Siponimod | 1件: D11460
D11460
| 2件: S1PR1 S1PR1, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
184 | Mayzent 2 mg Filmtabletten | 1件: Siponimod Siponimod | 1件: D11460
D11460
| 2件: S1PR1 S1PR1, S1PR5 💬 | 3件: FoxO signaling pathway FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 13 13 |
185 | MB-102 | - | - | - | - | 1件: 96 96 |
186 | MBM-01 | - | - | - | - | 1件: 65 65 |
187 | MBP peptide | - | - | - | - | 1件: 13 13 |
188 | MBP8298 | - | - | - | - | 1件: 13 13 |
189 | MBP8298 Synthetic Peptide | - | - | - | - | 1件: 13 13 |
190 | MBS2320 | - | - | - | - | 1件: 46 46 |
191 | MBT | - | - | - | - | 1件: 212 212 |
192 | MBX 8025 | - | - | - | - | 1件: 93 93 |
193 | MBX-8025 | - | - | - | - | 3件: 79 79, 93, 94 |
194 | MBX-8025 10 mg Capsule | - | - | - | - | 1件: 93 93 |
195 | MBX-8025 2 mg Capsule | - | - | - | - | 1件: 93 93 |
196 | MBX-8025 5 mg Capsule | - | - | - | - | 1件: 93 93 |
197 | MBX-8025 50 mg (Dose Escalation Period 1) | - | - | - | - | 1件: 79 79 |
198 | MBX-8025 50 mg or 100 mg (Dose Escalation Period 2) | - | - | - | - | 1件: 79 79 |
199 | MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3) | - | - | - | - | 1件: 79 79 |
200 | MBX-8025, DSIC | - | - | - | - | 1件: 93 93 |
201 | MBX-8025, Formulation 2 | - | - | - | - | 1件: 93 93 |
202 | MC1 | - | - | - | - | 1件: 46 46 |
203 | MCI-186 | - | - | - | - | 1件: 2 2 |
204 | MCI-186 in open label phase | - | - | - | - | 1件: 2 2 |
205 | MCT | - | - | - | - | 2件: 6 6, 296 |
206 | MCT powder | - | - | - | - | 1件: 296 296 |
207 | MCTLs | - | - | - | - | 1件: 65 65 |
208 | MD-0901 | - | - | - | - | 1件: 97 97 |
209 | MD-711 | - | - | - | - | 1件: 86 86 |
210 | MD1003 | - | - | - | - | 5件: 2 2, 10, 13, 14, 20 |
211 | MD1003 100 mg capsule | - | - | - | - | 1件: 20 20 |
212 | MD1003 100mg capsule | - | - | - | - | 1件: 13 13 |
213 | MDA | - | - | - | - | 1件: 46 46 |
214 | MDGN-002 | - | - | - | - | 1件: 96 96 |
215 | MDX-1100 | - | - | - | - | 3件: 46 46, 96, 97 |
216 | MDX-1100 (anti-CXCL10 human monoclonal antibody) | - | - | - | - | 1件: 97 97 |
217 | MDX-1342 | - | - | - | - | 1件: 46 46 |
218 | ME2080 (stiripentol) | 1件: Stiripentol Stiripentol | 1件: D05928
D05928
| - | - | 1件: 140 140 |
219 | ME2125 (safinamide mesilate) | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
220 | Measles, Mumps, Rubella vaccination | - | - | - | - | 1件: 107 107 |
221 | Measurement of growth, thyroid and sex hormone levels | 1件: Thyroid, porcine Thyroid, porcine | - | - | - | 1件: 78 78 |
222 | Measurement of serum infliximab and anti-infliximab antibodies | 1件: Infliximab Infliximab | 1件: D02598
D02598
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 |
223 | Measurment with Aspirational Medical Device | - | - | - | - | 1件: 51 51 |
224 | Measurment with Cutometer MPA 580 | - | - | - | - | 1件: 51 51 |
225 | Mecasermin | 1件: Mecasermin Mecasermin | 2件: D03297
D03297
,
D04870
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 5件: 78 78, 96, 168, 265, 299 |
226 | Mecasermin [rDNA Origin] 10mg/ml solution | 1件: Mecasermin Mecasermin | 2件: D03297
D03297
,
D04870
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 96 96 |
227 | MECASERMINA | 1件: Mecasermin Mecasermin | 2件: D03297
D03297
,
D04870
| 2件: GHR GHR, IGF1R 💬 | 33件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 78 78 |
228 | Mechanical stimulation with Von Frey filaments | - | - | - | - | 1件: 19 19 |
229 | Mecobalamin | 1件: Mecobalamin Mecobalamin | 1件: D03246
D03246
| - | - | 2件: 2 2, 70 |
230 | MEDI 545 | - | - | - | - | 1件: 49 49 |
231 | MEDI-522 | - | - | - | - | 1件: 46 46 |
232 | MEDI-545 | - | - | - | - | 2件: 49 49, 50 |
233 | MEDI-545 600 | - | - | - | - | 1件: 49 49 |
234 | MEDI-546 | - | - | - | - | 2件: 49 49, 51 |
235 | MEDI-551 | - | - | - | - | 2件: 13 13, 51 |
236 | MEDI-551 100 MG-IV | - | - | - | - | 1件: 13 13 |
237 | MEDI-551 30 MG-IV | - | - | - | - | 1件: 13 13 |
238 | MEDI-551 300 MG-SC | - | - | - | - | 1件: 13 13 |
239 | MEDI-551 60 MG-SC | - | - | - | - | 1件: 13 13 |
240 | MEDI-551 600 MG-IV | - | - | - | - | 1件: 13 13 |
241 | MEDI-563 | - | - | - | - | 5件: 44 44, 45, 98, 162, 299 |
242 | MEDI-570 0.03 MG | - | - | - | - | 1件: 49 49 |
243 | MEDI-570 0.1 MG | - | - | - | - | 1件: 49 49 |
244 | MEDI-570 0.3 MG | - | - | - | - | 1件: 49 49 |
245 | MEDI-570 1 MG | - | - | - | - | 1件: 49 49 |
246 | MEDI1341 | - | - | - | - | 1件: 6 6 |
247 | MEDI2070 | - | - | - | - | 2件: 96 96, 97 |
248 | MEDI4920 | - | - | - | - | 1件: 53 53 |
249 | MEDI5117 | - | - | - | - | 1件: 46 46 |
250 | MEDI7183 high dose | - | - | - | - | 1件: 97 97 |
251 | MEDI7183 low dose | - | - | - | - | 1件: 97 97 |
252 | MEDI7183 medium dose | - | - | - | - | 1件: 97 97 |
253 | MEDI7734 | - | - | - | - | 1件: 50 50 |
254 | MediCabilis CBD Oil | - | - | - | - | 1件: 2 2 |
255 | Medical air | 2件: Medical air Medical air, Oxygen | 1件: D00003
D00003
| - | - | 3件: 85 85, 86, 193 |
256 | Medical air (sham O2) | 2件: Medical air Medical air, Oxygen | 1件: D00003
D00003
| - | - | 1件: 85 85 |
257 | Medical Air vs Oxygen | 2件: Medical air Medical air, Oxygen | 1件: D00003
D00003
| - | - | 1件: 193 193 |
258 | Medical Cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 6 6 |
259 | Medical Grade Oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 299 299 |
260 | Medical Marijuana | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 13 13 |
261 | Medical Standard of Care for ITP | - | - | - | - | 1件: 63 63 |
262 | Medication Event Monitoring System (MEMS) | - | - | - | - | 1件: 13 13 |
263 | Medication to suppress the immune system | - | - | - | - | 1件: 19 19 |
264 | Medicinal air | - | - | - | - | 1件: 149 149 |
265 | Medicine | - | - | - | - | 1件: 2 2 |
266 | Medikinet | - | - | - | - | 1件: 240 240 |
267 | Medium chain triglyceride | 1件: Medium-chain triglycerides Medium-chain triglycerides | - | - | - | 1件: 318 318 |
268 | Medium chain triglycerides | - | - | - | - | 1件: 96 96 |
269 | Medium dose prednisolone | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
270 | Medium dose TSO | - | - | - | - | 1件: 96 96 |
271 | Medium Dose-VIS649 | - | - | - | - | 1件: 66 66 |
272 | Medium THC/medium CBD | - | - | - | - | 1件: 46 46 |
273 | Medrol | - | - | - | - | 4件: 13 13, 46, 56, 222 |
274 | MEDROL - 4 MG COMPRESSE 30 COMPRESSE | - | - | - | - | 1件: 56 56 |
275 | Medrol 4 mg tablets | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
276 | Medrol A 16 mg tablets | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
277 | MEDROL*10CPR DIV 4MG | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 |
278 | Medrone | - | - | - | - | 4件: 46 46, 51, 83, 162 |
279 | Medroxyprogesterone | - | - | - | - | 1件: 49 49 |
280 | MEFLOQUINE | 1件: Mefloquine Mefloquine | 1件: D04895
D04895
| - | - | 2件: 25 25, 46 |
281 | MEG | - | - | - | - | 1件: 6 6 |
282 | Megadose oral methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
283 | Megestrol acetate | 2件: Acetate Acetate, Megestrol acetate | 2件: D00952
D00952
,
D08167
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 76 76 |
284 | Megestrol Acetate Tablet | 2件: Acetate Acetate, Megestrol acetate | 2件: D00952
D00952
,
D08167
| 1件: PGR PGR 💬 | 5件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 76 76 |
285 | Meglumine | 1件: Meglumine Meglumine | 1件: D01796
D01796
| - | - | 2件: 28 28, 53 |
286 | MEK162 | - | - | - | - | 2件: 58 58, 195 |
287 | Mekinist | 1件: Trametinib Trametinib | 1件: D10175
D10175
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 2件: 34 34, 280 |
288 | Melarsoprol | 1件: Melarsoprol Melarsoprol | 1件: D00832
D00832
| - | - | 1件: 65 65 |
289 | Melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d | 2件: Eflornithine Eflornithine, Melarsoprol | 2件: D00832
D00832
,
D07883
| 1件: ODC1 ODC1 💬 | 3件: Arginine and proline metabolism Arginine and proline metabolism, Glutathione metabolism, Metabolic pathways 💬 | 1件: 65 65 |
290 | Melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d | 2件: Melarsoprol Melarsoprol, Nifurtimox | 2件: D00832
D00832
,
D00833
| - | - | 1件: 65 65 |
291 | Melatonin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
292 | Melatonin CR | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 202 202 |
293 | Melatonin PR | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
294 | Melatonin(Circadin®) | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
295 | Melevodopa | 1件: Melevodopa Melevodopa | 1件: D07304
D07304
| - | - | 1件: 6 6 |
296 | Melevodopa and decarboxylase inhibitor | 1件: Melevodopa Melevodopa | 1件: D07304
D07304
| - | - | 1件: 6 6 |
297 | MELFLUFEN | 1件: Melphalan flufenamide Melphalan flufenamide | 1件: D11865
D11865
| - | - | 1件: 28 28 |
298 | MELISSAE FOLII DRY AQUEOUS EXTRACT | - | - | - | - | 1件: 97 97 |
299 | Melissenblätter 15ml/10ml | - | - | - | - | 1件: 97 97 |
300 | Melitracen | 1件: Melitracen Melitracen | 1件: D08171
D08171
| - | - | 1件: 97 97 |
301 | Meloxicam | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 46 46, 49, 271, 296 |
302 | Meloxicam 0.125 mg/kg | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
303 | Meloxicam 0.25 mg/kg | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
304 | Meloxicam ampoule | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
305 | Meloxicam oral suspension | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
306 | Meloxicam suppository | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 271 271 |
307 | Meloxicam tablet | 1件: Meloxicam Meloxicam | 1件: D00969
D00969
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 46 46, 271 |
308 | Melperon | - | - | - | - | 1件: 6 6 |
309 | Melperone | 1件: Melperone Melperone | 1件: D07309
D07309
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
310 | Melperone HCl | 1件: Melperone Melperone | 1件: D07309
D07309
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
311 | Melphalan | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 15件: 11 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 |
312 | Melphalan fulfenamide hydrochloride | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 1件: 28 28 |
313 | Melphalan Hydrochloride | 1件: Melphalan Melphalan | 1件: D00369
D00369
| - | - | 1件: 60 60 |
314 | Melphalan, thalidomide and dexamethasone | 3件: Dexamethasone Dexamethasone, Melphalan, Thalidomide | 11件: D00292
D00292
,
D00369
,
D00754
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 2件: NR3C1 NR3C1, TNF 💬 | 68件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 28 28 |
315 | Melphalan-Flufenamide (Melflufen) | 2件: Melphalan Melphalan, Melphalan flufenamide | 2件: D00369
D00369
,
D11865
| - | - | 1件: 28 28 |
316 | Memantin Orion | - | - | - | - | 1件: 6 6 |
317 | Memantine | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 7件: 2 2, 6, 8, 13, 49, 127, 205 |
318 | Memantine (drug) | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
319 | Memantine (Ebixa) | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 |
320 | MEMANTINE HYDROCHLORIDE | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 127 |
321 | Memantine Hydrochloride Oral Solution | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 |
322 | Menadiol Diphosphate | 1件: Menadiol diphosphate Menadiol diphosphate | 1件: D08176
D08176
| - | - | 1件: 299 299 |
323 | Menadiol sodium diphosphate | 1件: Kappadione Kappadione | 1件: D04908
D04908
| - | - | 1件: 299 299 |
324 | Menatetrenone | 1件: Menatetrenone Menatetrenone | 1件: D00100
D00100
| - | - | 1件: 66 66 |
325 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 |
326 | MENINGOCOCCAL GROUP A OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 |
327 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (beta197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 |
328 | MENINGOCOCCAL GROUP W OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (ß197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 |
329 | MENINGOCOCCAL GROUP Y OLIGOSACCHARIDES CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE C7 (Â197) M8 (CRM197) PROTEIN | 2件: Corynebacterium diphtheriae Corynebacterium diphtheriae, Corynebacterium diphtheriae CRM197 protein | - | - | - | 1件: 11 11 |
330 | Meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent) | - | - | - | - | 1件: 13 13 |
331 | Menitorix | - | - | - | - | 1件: 13 13 |
332 | Menjugate | - | - | - | - | 1件: 14 14 |
333 | Mensa | - | - | - | - | 1件: 96 96 |
334 | MENTHA × PIPERITA L. FOLIUM | - | - | - | - | 1件: 97 97 |
335 | Menveo | 1件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | 6件: 11 11, 13, 61, 62, 66, 222 |
336 | MENVEO - POLV.E SOLUZ.PER SOLUZ. INIETT.-USO INTRAMUSCOLARE-COMP. CONIUG.LIOFILIZZ.MENA:FLAC.(VETRO) COMP. GONIUG.LIQUI.MENCWY:FLAC.(VETRO)-1 FLAC+1FLAC | 1件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | 2件: 62 62, 66 |
337 | MENVEO – Polvere e soluzione per soluzione iniettabile | 1件: Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine | - | - | - | 2件: 61 61, 62 |
338 | MEOPA | - | - | - | - | 1件: 149 149 |
339 | MEPOLIZUMAB | 1件: Mepolizumab Mepolizumab | 1件: D04923
D04923
| 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 4件: 44 44, 45, 98, 162 |
340 | Mepolizumab (a-IL-5 antibody) | 1件: Mepolizumab Mepolizumab | 1件: D04923
D04923
| 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 162 162 |
341 | Mepolizumab 100 mg | 1件: Mepolizumab Mepolizumab | 1件: D04923
D04923
| 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 98 98 |
342 | Mepolizumab 300 mg | 1件: Mepolizumab Mepolizumab | 1件: D04923
D04923
| 1件: IL5 IL5 💬 | 13件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | 1件: 98 98 |
343 | Mepsevii | 1件: Vestronidase alfa Vestronidase alfa | 1件: D11004
D11004
| 1件: GUSB GUSB 💬 | 8件: Ascorbate and aldarate metabolism Ascorbate and aldarate metabolism, Biosynthesis of cofactors, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome, Metabolic pathways, Pentose and glucuronate interconversions, Porphyrin metabolism 💬 | 1件: 19 19 |
344 | Mercaptamina | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 19 19 |
345 | Mercaptamine | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 19 19 |
346 | MERCAPTAMINE BITARTRATE | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 19 19 |
347 | MERCAPTAMINE HYDROCHLORIDE | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 19 19 |
348 | Mercaptamine, mercamine, 2-aminoethanethiol | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 1件: 19 19 |
349 | Mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: D00161
D00161
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 4件: 65 65, 96, 97, 164 |
350 | Mercaptopurine (Puri-Nethol) | 1件: Mercaptopurine Mercaptopurine | 2件: D00161
D00161
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 97 97 |
351 | Mercaptopurine (Purinethol) | 1件: Mercaptopurine Mercaptopurine | 2件: D00161
D00161
,
D04931
| 1件: HPRT1 HPRT1 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 97 97 |
352 | Meriva | - | - | - | - | 1件: 46 46 |
353 | MEROPENEM | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 2件: 60 60, 299 |
354 | Meropenem Fresenius Kabi | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
355 | Meropenem Fresenius Kabi 1 g poeder voor oplossing voor injectie of infusie | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
356 | Meropenem Infusion | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
357 | MEROPENEM TRIHYDRATE | 1件: Meropenem Meropenem | 2件: D02222
D02222
,
D08185
| - | - | 1件: 299 299 |
358 | Mesalamin | - | - | - | - | 1件: 97 97 |
359 | Mesalamine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 3件: 96 96, 97, 164 |
360 | Mesalamine Delayed Release Tablets 400mg | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
361 | Mesalamine Enema | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
362 | Mesalamine Granules | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
363 | Mesalamine Once-Daily | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
364 | Mesalamine Twice-Daily | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
365 | Mesalamine, 5-aminosalicylic acid | 2件: Aminosalicylic acid Aminosalicylic acid, Mesalazine | 2件: D00162
D00162
,
D00377
| - | - | 1件: 96 96 |
366 | Mesalamine, 5-aminosalicylic acid [5-ASA] | 2件: Aminosalicylic acid Aminosalicylic acid, Mesalazine | 2件: D00162
D00162
,
D00377
| - | - | 1件: 97 97 |
367 | Mesalamine, 5-ASA | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
368 | MESALAZINA | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
369 | Mesalazine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 3件: 46 46, 96, 97 |
370 | Mesalazine (3,600 mg) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
371 | Mesalazine (Asacol®) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
372 | Mesalazine (Mesalamine) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 96 96 |
373 | Mesalazine - TID 1000 mg | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
374 | Mesalazine - TID 2x 500 mg | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
375 | Mesalazine 1000 mg gastro-resistant tablets | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
376 | Mesalazine 250Mg | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
377 | Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet | 2件: Mesalazine Mesalazine, Nitazoxanide | 2件: D00377
D00377
,
D02486
| - | - | 1件: 97 97 |
378 | Mesalazine 4G Enema | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
379 | Mesalazine 500 mg gastro-resistant tablets (Salofa | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
380 | Mesalazine 500 mg gastro-resistant tablets (Salofalk® 500 mg) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
381 | Mesalazine EC 500 mg | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 96 96 |
382 | Mesalazine Enema | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
383 | Mesalazine liquid enema | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
384 | Mesalazine slow-release granules | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
385 | Mesalazine Sustained-Release Tablets | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 96 96 |
386 | Mesalazine tablet | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
387 | Mesalazine tablets | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 96 96 |
388 | Mesalazine with hydrocortisone sodium succinate | 2件: Hydrocortisone Hydrocortisone, Mesalazine | 2件: D00088
D00088
,
D00377
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 97 97 |
389 | Mesalazine, Tripterygium glycosides | 2件: Mesalazine Mesalazine, Tripterygium wilfordii whole | 1件: D00377
D00377
| - | - | 1件: 96 96 |
390 | Mesalazinum | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
391 | Mesdopetam | 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 |
392 | Mesdopetam (IRL790) | 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 |
393 | Mesencephalic Neuronal Precursor Cells | - | - | - | - | 1件: 6 6 |
394 | Mesenchymal cell and fibroblast injection | - | - | - | - | 1件: 96 96 |
395 | Mesenchymal cell transplantation | - | - | - | - | 2件: 46 46, 96 |
396 | MESENCHYMAL CELLS | - | - | - | - | 1件: 97 97 |
397 | Mesenchymal stem cell | - | - | - | - | 1件: 2 2 |
398 | Mesenchymal stem cell 0.5 | - | - | - | - | 1件: 228 228 |
399 | Mesenchymal stem cell 1.0 | - | - | - | - | 1件: 228 228 |
400 | Mesenchymal stem cell transplantation | - | - | - | - | 2件: 36 36, 274 |
401 | Mesenchymal stem cells | - | - | - | - | 11件: 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
402 | Mesenchymal stem cells (MSC) | - | - | - | - | 3件: 2 2, 13, 96 |
403 | Mesenchymal stem cells (MSCs) | - | - | - | - | 3件: 13 13, 36, 96 |
404 | Mesenchymal stem cells derived from bone marrow (BM-MSCs) | - | - | - | - | 1件: 36 36 |
405 | Mesenchymal Stem Cells extracted from bone marrow | - | - | - | - | 1件: 36 36 |
406 | Mesenchymal Stem Cells from Wharton ´s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ´s jelly | - | - | - | - | 1件: 51 51 |
407 | Mesenchymal stem cells isolated from Wharton's jelly | - | - | - | - | 1件: 2 2 |
408 | Mesenchymal stem/stromal cells | - | - | - | - | 1件: 13 13 |
409 | Mesenchymal Stromal Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 10件: 2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 |
410 | Mesenchymal stromal cells (MSC) for infusion | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 96 96 |
411 | Mesna | 1件: Coenzyme M Coenzyme M | - | - | - | 11件: 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 |
412 | Mestinon | 1件: Pyridostigmine Pyridostigmine | 1件: D00487
D00487
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 3 3, 6, 11 |
413 | MET-2 | - | - | - | - | 1件: 97 97 |
414 | Metabolic balance measurements | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 81 81 |
415 | Metabolic Cofactor Supplementation | - | - | - | - | 1件: 6 6 |
416 | Metabolic fatigue | - | - | - | - | 1件: 13 13 |
417 | Metabolic profile | - | - | - | - | 1件: 113 113 |
418 | Metafolin | - | - | - | - | 1件: 201 201 |
419 | Metal on Polyethylene articulation | - | - | - | - | 1件: 46 46 |
420 | Metal Radial Head | - | - | - | - | 1件: 46 46 |
421 | Metal Radial Head replacement | - | - | - | - | 1件: 46 46 |
422 | Metalcaptase | - | - | - | - | 1件: 171 171 |
423 | Metalcaptase® 150 mg gastro-resistant tablet | - | - | - | - | 1件: 171 171 |
424 | Metalcaptase® 300 mg gastro-resistant tablet | - | - | - | - | 1件: 171 171 |
425 | Metamizole | 1件: Metamizole Metamizole | 1件: D08188
D08188
| - | - | 1件: 298 298 |
426 | Metazym | - | - | - | - | 1件: 19 19 |
427 | Metex | - | - | - | - | 2件: 13 13, 46 |
428 | Metex 10 mg/ml Injektionslösung, Fertigspritze | - | - | - | - | 1件: 46 46 |
429 | Metex 10mg Tabletten | - | - | - | - | 1件: 46 46 |
430 | Metex 2,5 mg Tabletten | - | - | - | - | 1件: 44 44 |
431 | Metex 2,5mg Tabletten | - | - | - | - | 1件: 46 46 |
432 | Metex 50 mg/ml injeksjonsvæske, oppløsning i ferdigfylt sprøyte | - | - | - | - | 1件: 46 46 |
433 | Metex 7,5mg Tabletten | - | - | - | - | 1件: 46 46 |
434 | Metex Pen | - | - | - | - | 1件: 46 46 |
435 | Metex® | - | - | - | - | 1件: 46 46 |
436 | Metex® 50 mg/ml Injektionslösung, Fertigspritze | - | - | - | - | 1件: 46 46 |
437 | Metformin | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
438 | Metformin (generic) | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 158 158 |
439 | Metformin 500 mg TID Oral Tablet | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 97 97 |
440 | Metformin 500mg | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
441 | Metformin and Metformin & L-Citrulline | 2件: Citrulline Citrulline, Metformin | 3件: D00944
D00944
,
D04966
,
D07706
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
442 | Metformin HCl | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 285 285 |
443 | METFORMIN HYDROCHLORIDE | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 5件: 81 81, 158, 265, 299, 301 |
444 | Metformin treatment | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 |
445 | Metformin XR | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 67 67 |
446 | Metformin/CP-690,550 | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 |
447 | METFORMINA | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 2件: 67 67, 113 |
448 | METFORMINA - 500 30 COMPRESSE 500 MG | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 113 113 |
449 | Metformine | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 3件: 46 46, 81, 299 |
450 | METFORMINE ARROW 500mg | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 46 46 |
451 | Metformine HCL 500 PCH | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 299 299 |
452 | Metformine Sandoz 850 mg filmomhulde tabletten | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 1件: 81 81 |
453 | Methacetin Breath Test (MBT) | - | - | - | - | 1件: 212 212 |
454 | Methacholine | 1件: Methacholine Methacholine | - | - | - | 1件: 96 96 |
455 | Methane | 1件: Methane Methane | - | - | - | 1件: 2 2 |
456 | Methelphenidate | - | - | - | - | 1件: 13 13 |
457 | Methimazole | 1件: Methimazole Methimazole | 1件: D00401
D00401
| 1件: TPO TPO 💬 | 4件: Autoimmune thyroid disease Autoimmune thyroid disease, Metabolic pathways, Thyroid hormone synthesis, Tyrosine metabolism 💬 | 1件: 50 50 |
458 | Methionine | 1件: Methionine Methionine | 2件: D00019
D00019
,
D04983
| - | - | 7件: 34 34, 75, 84, 93, 229, 298, 300 |
459 | Methorexate | - | - | - | - | 1件: 46 46 |
460 | Methotrexaat | - | - | - | - | 1件: 46 46 |
461 | Methotrexat | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 4件: 13 13, 46, 50, 96 |
462 | Methotrexat 2,5 mg Tabletten medac | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
463 | Methotrexat HEXAL® 2,5 mg Tabletten | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
464 | Methotrexat Lachema 2,5mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
465 | Methotrexat Lachema 2,5mg tbl. | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
466 | Methotrexat Lachema 5 inj. sol | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
467 | METHOTREXAT Lederle - Tabletten | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
468 | Methotrexat Lederle 2.5mg tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
469 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 38件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 283, 284, 285, 286, 326, 331 |
470 | Methotrexate 'Lederle' 2,5mg tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
471 | Methotrexate 'Lederle' 2.5mg Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
472 | Methotrexate 'Lederle' Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
473 | Methotrexate (Metoject® prefilled pen) | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
474 | Methotrexate (MTX) | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
475 | Methotrexate (stable dose) | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
476 | Methotrexate (tapering dose) | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
477 | Methotrexate + biologic administration | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
478 | Methotrexate + Infliximab | 2件: Infliximab Infliximab, Methotrexate | 3件: D00142
D00142
,
D02115
,
D02598
| 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
479 | Methotrexate + Methylprednisolone | 2件: Methotrexate Methotrexate, Methylprednisolone | 8件: D00142
D00142
,
D00407
,
D00751
,
D00979
,
D02115
,
D05000
,
D05001
,
D05002
| 3件: DHFR DHFR, DHFR2, NR3C1 💬 | 6件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, Neuroactive ligand-receptor interaction, One carbon pool by folate 💬 | 1件: 46 46 |
480 | Methotrexate + salazopyrine + hydroxychloroquine administration | 2件: Hydroxychloroquine Hydroxychloroquine, Methotrexate | 3件: D00142
D00142
,
D02115
,
D08050
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
481 | METHOTREXATE - 20 MG/0.8 ML SOLUZIONE INIETTABILE 4 SIRINGHE PRERIEMPITE MONOUSO DA 1.25 ML | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 96 96 |
482 | Methotrexate - Amneal | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
483 | Methotrexate - DAVA | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
484 | Methotrexate - Delay | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
485 | Methotrexate - etanercept - prednisolone arm | 3件: Etanercept Etanercept, Methotrexate, Prednisolone | 11件: D00142
D00142
,
D00472
,
D00742
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02115
,
D02156
,
D03301
| 5件: DHFR DHFR, DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 107 |
486 | Methotrexate - Immediate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
487 | Methotrexate 10 mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
488 | Methotrexate 10 mg tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
489 | Methotrexate 2.5 mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 |
490 | METHOTREXATE 2.5 mg tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
491 | Methotrexate 2.5mg Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
492 | Methotrexate 2.5mg Tablets BP | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
493 | Methotrexate 25 mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 |
494 | Methotrexate 50mg/ml solution for injection, pre-filled syringe | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
495 | Methotrexate ``Lederle`` 2.5mg tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
496 | Methotrexate alone | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 107 107 |
497 | Methotrexate and folic acid | 2件: Folic acid Folic acid, Methotrexate | 3件: D00070
D00070
,
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 49 49 |
498 | Methotrexate as methotrexate disodium | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
499 | Methotrexate bellon | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 97 97 |
500 | Methotrexate bellon 25mg/ml | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 97 97 |
501 | Methotrexate capsules | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
502 | METHOTREXATE DISODIUM | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 5件: 46 46, 96, 97, 107, 271 |
503 | Methotrexate Ebewe | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
504 | METHOTREXATE HOSPIRA 2,5 mg tablety | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
505 | METHOTREXATE HOSPIRA 2.5 mg tablety | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
506 | Methotrexate injection | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 96 96, 97 |
507 | Methotrexate Lachema 5inj. sol | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
508 | Methotrexate Lederle 2.5 mg Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
509 | Methotrexate Pfizer 2,5 mg tabletter | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
510 | Methotrexate Placebo | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
511 | Methotrexate plus ENBREL or ENBREL alone | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
512 | Methotrexate plus ERB-041 for 12 weeks | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
513 | Methotrexate plus sulfasalazine | 2件: Methotrexate Methotrexate, Sulfasalazine | 3件: D00142
D00142
,
D00448
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
514 | Methotrexate pre-filled pen | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
515 | Methotrexate prefilled pen | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 107 |
516 | Methotrexate prefilled syringe | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
517 | METHOTREXATE SODIUM | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 256 |
518 | Methotrexate Sodium 2.5mg Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
519 | Methotrexate Sodium Tablets 2.5 mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
520 | Methotrexate Sodium Tablets 2.5mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
521 | Methotrexate Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 40 40 |
522 | Methotrexate tablets 2.5 mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
523 | Methotrexate treatment | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 41 41, 46 |
524 | Methotrexate Wyeth 2,5mg | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
525 | Methotrexate Wyeth 2,5mg tbl. | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
526 | Methotrexate ® 2.5mg Tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
527 | Methotrexate(MTX) | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
528 | Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
529 | Methotrexate(MTX) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
530 | Methotrexate(necessary) | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
531 | METHOTREXATE*100CPR 2,5MG | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
532 | METHOTREXATE*10MG/1,33ML 4S | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
533 | METHOTREXATE*15MG/2ML 4SIR | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
534 | METHOTREXATE*2,5MG 25CPR | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
535 | METHOTREXATE*20MG/2,66ML 4S | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
536 | METHOTREXATE*25CPR 2,5MG | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 107 |
537 | METHOTREXATE*7,5MG/ML 4SIR. | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
538 | Methotrexate, Leucovorin and BMS-986142 | 3件: BMS-986142 BMS-986142, Leucovorin, Methotrexate | 5件: D00142
D00142
,
D01211
,
D02115
,
D07986
,
D07987
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
539 | Methotrexate,Adalimumab | 2件: Adalimumab Adalimumab, Methotrexate | 3件: D00142
D00142
,
D02115
,
D02597
| 3件: DHFR DHFR, DHFR2, TNF 💬 | 71件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 |
540 | Methotrexate-Lachema | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
541 | Methotrexate-Sulfasalazine-Hydroxychloroquine | 3件: Hydroxychloroquine Hydroxychloroquine, Methotrexate, Sulfasalazine | 4件: D00142
D00142
,
D00448
,
D02115
,
D08050
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
542 | Methotrexate® 2.5 mg tablets | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
543 | Methotrextate | - | - | - | - | 1件: 46 46 |
544 | Methoxsalen | 1件: Methoxsalen Methoxsalen | 1件: D00139
D00139
| - | - | 4件: 36 36, 46, 51, 96 |
545 | Methoxsalen +ECP | 1件: Methoxsalen Methoxsalen | 1件: D00139
D00139
| - | - | 1件: 96 96 |
546 | Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-beta-Dribofuronamide | 1件: Adenine Adenine | 1件: D00034
D00034
| - | - | 1件: 46 46 |
547 | Methyl 1-[N6-(3-iodobenzyl)-adenin-9-yl]-ß-Dribofuronamide | 1件: Adenine Adenine | 1件: D00034
D00034
| - | - | 1件: 46 46 |
548 | Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo | - | - | - | - | 1件: 86 86 |
549 | Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb | - | - | - | - | 2件: 86 86, 88 |
550 | Methyl [4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]meth | - | - | - | - | 2件: 86 86, 88 |
551 | Methyl B12 | - | - | - | - | 1件: 13 13 |
552 | Methyl cellulose | 2件: Methylcellulose Methylcellulose, Microcrystalline cellulose | 2件: D00093
D00093
,
D04996
| - | - | 1件: 53 53 |
553 | Methyl folate | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 1件: 13 13 |
554 | Methyl Prednisolonate | - | - | - | - | 1件: 13 13 |
555 | Methyl prednisolone | 1件: Prednisolone Prednisolone | 8件: D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 43 43, 49, 96 |
556 | Methylaminopterin | - | - | - | - | 1件: 46 46 |
557 | Methylcobalamin | 1件: Mecobalamin Mecobalamin | 1件: D03246
D03246
| - | - | 1件: 2 2 |
558 | Methyldopa | 1件: Methyldopa Methyldopa | 2件: D00405
D00405
,
D08205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 323 323 |
559 | Methylene blue | 1件: Methylene blue Methylene blue | 2件: D02312
D02312
,
D10537
| - | - | 2件: 46 46, 97 |
560 | Methylene blue 25mg tablets | 1件: Methylene blue Methylene blue | 2件: D02312
D02312
,
D10537
| - | - | 1件: 97 97 |
561 | Methylene blue mediated Photodynamic therapy | 1件: Methylene blue Methylene blue | 2件: D02312
D02312
,
D10537
| - | - | 1件: 46 46 |
562 | Methyloprednisolone | - | - | - | - | 1件: 13 13 |
563 | Methylorednisolone | - | - | - | - | 1件: 56 56 |
564 | Methylphenidate | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 7件: 6 6, 13, 34, 84, 113, 179, 206 |
565 | Methylphenidate (MPD) | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 6 6 |
566 | Methylphenidate (overencapsulated) | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 84 84 |
567 | Methylphenidate 10mg tablets | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 84 84 |
568 | METHYLPHENIDATE HYDROCHLORIDE | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
569 | Methylphenidate modified release | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
570 | Methylphenidate modified release 20 mg | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
571 | Methylphenidate modified release 30 mg | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
572 | Methylphenidate modified release 40 mg | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 13 13 |
573 | Methylphenidate, fluoxetin, risperidone | 3件: Fluoxetine Fluoxetine, Methylphenidate, Risperidone | 5件: D00326
D00326
,
D00426
,
D00823
,
D01296
,
D04999
| 5件: DRD2 DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬 | 2件: 179 179, 206 |
574 | Methylphenylpyrazolone | 1件: Edaravone Edaravone | 1件: D01552
D01552
| - | - | 1件: 2 2 |
575 | Methylprednisolon | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 4件: 13 13, 14, 51, 66 |
576 | Methylprednisolon (Solu-Medrol) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 14 14 |
577 | Methylprednisolon-21-hydrogensuccinat, Natriumsalz | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
578 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
579 | Methylprednisolone (drug) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
580 | Methylprednisolone (MP) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 60 60, 285 |
581 | Methylprednisolone (MP) or prednisone (pred) | 2件: Methylprednisolone Methylprednisolone, Prednisone | 7件: D00407
D00407
,
D00473
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
582 | Methylprednisolone (or other glucocorticoid) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 43 43 |
583 | Methylprednisolone (Solu-Medrol) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 14 14 |
584 | Methylprednisolone 1250 mg/24h x3 days | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
585 | METHYLPREDNISOLONE ACETATE | 2件: Acetate Acetate, Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 46 46, 51 |
586 | Methylprednisolone and azathioprine | 2件: Azathioprine Azathioprine, Methylprednisolone | 8件: D00238
D00238
,
D00407
,
D00751
,
D00979
,
D03033
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 93 93, 95 |
587 | Methylprednisolone and Mycophenolate mofetil | 3件: Methylprednisolone Methylprednisolone, Mycophenolate mofetil, Mycophenolic acid | 10件: D00407
D00407
,
D00751
,
D00752
,
D00979
,
D05000
,
D05001
,
D05002
,
D05094
,
D05095
,
D05096
| 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 2件: 93 93, 95 |
588 | Methylprednisolone bolus IV 15 mg/kg/d for 3 days. | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 |
589 | Methylprednisolone hemisuccinate | 2件: Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
590 | Methylprednisolone IV | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
591 | METHYLPREDNISOLONE MYLAN Générique | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
592 | Methylprednisolone or budesonide | 2件: Budesonide Budesonide, Methylprednisolone | 7件: D00246
D00246
,
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 |
593 | Methylprednisolone or Prednisolone | 2件: Methylprednisolone Methylprednisolone, Prednisolone | 14件: D00407
D00407
,
D00472
,
D00751
,
D00979
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 65 65 |
594 | Methylprednisolone PO | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
595 | Methylprednisolone pulse | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 66 66, 220 |
596 | METHYLPREDNISOLONE SODIUM HEMISUCCINATE | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 13 13, 97 |
597 | METHYLPREDNISOLONE SODIUM SUCCINATE | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 13 13, 46, 49, 50, 51, 211 |
598 | Methylprednisolone succinate | 2件: Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 13 13 |
599 | Methylprednisolone(intravenously in the 1st-2nd-3rd month ) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
600 | Methylprednisolone(intravenously in the 1st-3rd-5th month) | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 66 66 |
601 | Methylprednisoloni natrii succinas | - | - | - | - | 1件: 50 50 |
602 | Methylprednisone | 1件: Methylprednisone Methylprednisone | - | - | - | 3件: 46 46, 66, 222 |
603 | Methylthioninium | 1件: Methylthioninium Methylthioninium | - | - | - | 1件: 127 127 |
604 | Methylthioninium chloride | 3件: Chloride ion Chloride ion, Methylene blue, Methylthioninium | 2件: D02312
D02312
,
D10537
| - | - | 1件: 127 127 |
605 | Metilprdnisolone | - | - | - | - | 1件: 11 11 |
606 | METILPREDNISOLONE | - | - | - | - | 6件: 11 11, 13, 53, 56, 63, 300 |
607 | METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO | - | - | - | - | 1件: 300 300 |
608 | Metilprednisolone sodio succinato | - | - | - | - | 3件: 13 13, 14, 56 |
609 | METOCLOPRAMIDE | 1件: Metoclopramide Metoclopramide | 3件: D00726
D00726
,
D02213
,
D05008
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 51 51 |
610 | METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL | 1件: Metoclopramide Metoclopramide | 3件: D00726
D00726
,
D02213
,
D05008
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 51 51 |
611 | MetoHEXAL® Succ ® 23,75 mg Retardtabletten | - | - | - | - | 1件: 113 113 |
612 | MetoHEXAL® Succ ® 47,5 mg Retardtabletten | - | - | - | - | 1件: 113 113 |
613 | MetoHEXAL® Succ ® 95 mg Retardtabletten | - | - | - | - | 1件: 113 113 |
614 | METOJECT | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 6件: 41 41, 46, 96, 97, 107, 271 |
615 | Metoject 10 mg/ml | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 50 50 |
616 | METOJECT 10 mg/ml, solution injectable en seringue pré-remplie | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 44 44 |
617 | Metopirone | 1件: Metyrapone Metyrapone | 2件: D00410
D00410
,
D05019
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
618 | Metopirone 250 mg capsules | 1件: Metyrapone Metyrapone | 2件: D00410
D00410
,
D05019
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
619 | Metopirone 250 mg capsules/ Cormeto | 1件: Metyrapone Metyrapone | 2件: D00410
D00410
,
D05019
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
620 | Metopirone 250 mg capsules/Cormeto | 1件: Metyrapone Metyrapone | 2件: D00410
D00410
,
D05019
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 1件: 75 75 |
621 | Metoprolol | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 17 17, 57, 58, 113, 193, 226 |
622 | Metoprolol succinate | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 57 57, 58, 113, 193 |
623 | METOPROLOL SUCCINATE (PH. EUR.) | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 193 193 |
624 | Metoprolol succinate + doxazosin | 2件: Doxazosin Doxazosin, Metoprolol | 5件: D00601
D00601
,
D00608
,
D02358
,
D05011
,
D07874
| 4件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 | 13件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 57 57 |
625 | Metoprolol tartrate 50 mg | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
626 | Metoprolol Tartrate Oral Tablet | 1件: Metoprolol Metoprolol | 3件: D00601
D00601
,
D02358
,
D05011
| 1件: ADRB1 ADRB1 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 226 226 |
627 | Metoprololsuccinat | - | - | - | - | 1件: 58 58 |
628 | Metoprololsuccinat Orion 25mg | - | - | - | - | 1件: 193 193 |
629 | Metoprololsuccinat ”Orion” 25mg | - | - | - | - | 1件: 193 193 |
630 | Metotab® | - | - | - | - | 1件: 46 46 |
631 | METOTRESSATO SALE SODICO | - | - | - | - | 1件: 46 46 |
632 | Metotrexat | - | - | - | - | 2件: 50 50, 96 |
633 | Metotrexat Orion | - | - | - | - | 1件: 46 46 |
634 | Metotrexate | - | - | - | - | 1件: 50 50 |
635 | METOTREXATO | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 2件: 46 46, 107 |
636 | METOTREXATO SANDOZ - 2.5 MG COMPRESSE 50 COMPRESSE IN FLACONE PP | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
637 | METOTREXATO SODICO | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
638 | METOTREXATO SODIO | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
639 | METOTREXATO-LEDERLE 2,5 MG COMPRIMIDOS | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
640 | METRELEPTIN | 1件: Metreleptin Metreleptin | 1件: D05014
D05014
| 1件: LEPR LEPR 💬 | 6件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬 | 1件: 265 265 |
641 | Metrelpetin | - | - | - | - | 1件: 265 265 |
642 | Metronidazol | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 2件: 46 46, 96 |
643 | METRONIDAZOLE | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 8件: 46 46, 51, 63, 94, 95, 96, 97, 291 |
644 | Metronidazole capsule 50 mg | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 1件: 97 97 |
645 | Metronidazole Oral | 1件: Metronidazole Metronidazole | 3件: D00409
D00409
,
D05016
,
D05017
| - | - | 1件: 96 96 |
646 | METYRAPONE | 1件: Metyrapone Metyrapone | 2件: D00410
D00410
,
D05019
| 1件: CYP11B1 CYP11B1 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Steroid hormone biosynthesis 💬 | 2件: 75 75, 193 |
647 | Metyyliprednisoloninatriumsuksinaatti | - | - | - | - | 1件: 211 211 |
648 | Mexiletina | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 |
649 | MEXILETINA CLORIDRATO | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 |
650 | Mexiletine | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 1 1, 2, 10, 113, 114 |
651 | Mexiletine 167 mg | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 113 113 |
652 | Mexitil | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 |
653 | MEXITIL*20CPS 200MG | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 114 114 |
654 | Mextrex | - | - | - | - | 1件: 46 46 |
655 | Mezagitamab | 1件: Mezagitamab Mezagitamab | 1件: D11945
D11945
| 1件: CD38 CD38 💬 | 7件: Calcium signaling pathway Calcium signaling pathway, Hematopoietic cell lineage, Metabolic pathways, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Salivary secretion 💬 | 1件: 66 66 |
656 | MEZAVANT | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
657 | Mezavant 1200 mg magensaftresistente Retardtabletten | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
658 | Mezavant Gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
659 | Mezavant XL | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
660 | Mezavant XL 1200 mg gastro-resistant prolonged release tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
661 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
662 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets. | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
663 | Mezavant XL 1200mg gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
664 | Mezavant XL Gastro-resistant, prolonged release tablets | 2件: Manganese citrate Manganese citrate, Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
665 | Mezym F | - | - | - | - | 1件: 298 298 |
666 | Mg | - | - | - | - | 4件: 6 6, 13, 51, 111 |
667 | MG-S-2525 | - | - | - | - | 1件: 85 85 |
668 | MG01CI extended-release tablet | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 206 206 |
669 | MGlu5 antagonist | - | - | - | - | 1件: 206 206 |
670 | MH002 | - | - | - | - | 1件: 97 97 |
671 | MH004 Ia(0.1%) | - | - | - | - | 1件: 46 46 |
672 | MH004 Ia(0.3%) | - | - | - | - | 1件: 46 46 |
673 | MH004 Ia(1%) | - | - | - | - | 1件: 46 46 |
674 | MH004 Ia(3%) | - | - | - | - | 1件: 46 46 |
675 | MH004 Ib-1(0.1%) | - | - | - | - | 1件: 46 46 |
676 | MH004 Ib-1(0.3%) | - | - | - | - | 1件: 46 46 |
677 | MH004 Ib-1(1%) | - | - | - | - | 1件: 46 46 |
678 | MH004 Ib-2(0.3%) | - | - | - | - | 1件: 46 46 |
679 | MH004 Ib-2(1%) | - | - | - | - | 1件: 46 46 |
680 | MH004 Ib-2(3%) | - | - | - | - | 1件: 46 46 |
681 | MHealth Intervention | - | - | - | - | 1件: 86 86 |
682 | MHS552 | - | - | - | - | 1件: 49 49 |
683 | MHSCT | - | - | - | - | 1件: 51 51 |
684 | MHV370 | - | - | - | - | 2件: 52 52, 53 |
685 | Miacalcic | - | - | - | - | 1件: 225 225 |
686 | MIB-626 | - | - | - | - | 1件: 18 18 |
687 | Micellar Paclitaxel for Injection | 1件: Paclitaxel Paclitaxel | 2件: D00491
D00491
,
D05333
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 46 46 |
688 | MICOFENOLATO MOFETILE | - | - | - | - | 1件: 53 53 |
689 | Micofenolato mofetilo | - | - | - | - | 1件: 35 35 |
690 | MICOFENOLICO ACIDO | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 49 49 |
691 | Micro Mouth Pressure Meter | - | - | - | - | 1件: 2 2 |
692 | Microalgal oil | - | - | - | - | 1件: 240 240 |
693 | MICROBIOTA | - | - | - | - | 1件: 96 96 |
694 | Microbiote fécal | - | - | - | - | 1件: 97 97 |
695 | Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF) | - | - | - | - | 2件: 85 85, 229 |
696 | Microgynon | - | - | - | - | 2件: 13 13, 51 |
697 | Microgynon® | - | - | - | - | 1件: 13 13 |
698 | Microgynon® 30 (Oral contraceptive) | - | - | - | - | 1件: 46 46 |
699 | Micropirin | - | - | - | - | 1件: 13 13 |
700 | Mid dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 |
701 | Midamor | 1件: Amiloride Amiloride | 2件: D00649
D00649
,
D07447
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬 | 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 225 225 |
702 | Midazolam | 1件: Midazolam Midazolam | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
703 | Midazolam 2 mg | 1件: Midazolam Midazolam | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 96 96, 97 |
704 | Midazolam 3 mg | 1件: Midazolam Midazolam | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 96 96 |
705 | Midazolam injection | 1件: Midazolam Midazolam | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 21 21 |
706 | Midodrine | 1件: Midodrine Midodrine | 2件: D01307
D01307
,
D08220
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 6 6, 17, 58 |
707 | MIDODRINE HYDROCHLORIDE | 1件: Midodrine Midodrine | 2件: D01307
D01307
,
D08220
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 |
708 | Midodrine or atomoxetine pill | 2件: Atomoxetine Atomoxetine, Midodrine | 4件: D01307
D01307
,
D02574
,
D07473
,
D08220
| 4件: ADRA1A ADRA1A, ADRA1B, ADRA1D, SLC6A2 💬 | 8件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Synaptic vesicle cycle, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 17 17 |
709 | Mifedren | - | - | - | - | 1件: 75 75 |
710 | MIFEPRISTONE | 1件: Mifepristone Mifepristone | 1件: D00585
D00585
| 2件: NR3C1 NR3C1, PGR 💬 | 6件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Neuroactive ligand-receptor interaction, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬 | 1件: 75 75 |
711 | MIGALASTAT | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
712 | Migalastat HCl | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
713 | Migalastat HCl 150 mg | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
714 | MIGALASTAT HYDROCHLORIDE | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
715 | Migalastat hydrocloride | 1件: Migalastat Migalastat | 1件: D10359
D10359
| - | - | 1件: 19 19 |
716 | MighTeaFlow | - | - | - | - | 1件: 53 53 |
717 | MIGLUSTAT | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 19 19, 256, 299 |
718 | Miglustat (AT2221) | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 256 256 |
719 | MIGLUSTAT (ZAVESCA) | 1件: Miglustat Miglustat | 1件: D05032
D05032
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
720 | Milatuzumab | 1件: Milatuzumab Milatuzumab | 1件: D08944
D08944
| 1件: CD74 CD74 💬 | 3件: Antigen processing and presentation Antigen processing and presentation, Herpes simplex virus 1 infection, Tuberculosis 💬 | 1件: 49 49 |
721 | Mild dose cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 13 13 |
722 | MILD Procedure | - | - | - | - | 1件: 70 70 |
723 | MILD® (Minimally Invasive Lumbar Decompression) | - | - | - | - | 1件: 70 70 |
724 | Milk | 1件: Cow milk Cow milk | - | - | - | 2件: 98 98, 210 |
725 | Milnacipran | 1件: Milnacipran Milnacipran | 1件: D08222
D08222
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 46 46, 49 |
726 | Milrinone | 1件: Milrinone Milrinone | 2件: D00417
D00417
,
D02085
| 2件: PDE3A PDE3A, PDE3B 💬 | 11件: Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 294 294 |
727 | Miltenyi Biotec CliniMACS | - | - | - | - | 2件: 62 62, 326 |
728 | Miltenyi CD34 Reagent System | - | - | - | - | 1件: 60 60 |
729 | Miltenyi CliniMACS | - | - | - | - | 3件: 62 62, 65, 285 |
730 | Miltenyi CliniMACS selection system | - | - | - | - | 1件: 65 65 |
731 | MIN-102 | - | - | - | - | 2件: 18 18, 20 |
732 | Mind-body therapy | - | - | - | - | 1件: 168 168 |
733 | Mineral boost (magnesium) | 1件: Magnesium Magnesium | - | - | - | 1件: 13 13 |
734 | MINGO | - | - | - | - | 1件: 120 120 |
735 | Minimally invasive fetoscopic repair of MMC | - | - | - | - | 1件: 118 118 |
736 | Minirin | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 2件: 64 64, 288 |
737 | Minocycline | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
738 | Minocycline 100 mg Film-coated Tablets | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 1件: 13 13 |
739 | Minocycline 100mg | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 1件: 13 13 |
740 | Minocycline Hydrochloride | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 4件: 13 13, 201, 206, 299 |
741 | Minocycline, then Minocycline/Lovastatin | 2件: Lovastatin Lovastatin, Minocycline | 3件: D00359
D00359
,
D00850
,
D05045
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 1件: 206 206 |
742 | Minodronate | 1件: Minodronic acid Minodronic acid | - | - | - | 1件: 46 46 |
743 | Minodronic acid | 1件: Minodronic acid Minodronic acid | - | - | - | 4件: 6 6, 46, 93, 95 |
744 | Minomycin | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 1件: 84 84 |
745 | Minor Salivary gland (labial) biopsy | - | - | - | - | 1件: 53 53 |
746 | MINOXIDIL | 1件: Minoxidil Minoxidil | 1件: D00418
D00418
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 1件: 179 179 |
747 | Minrin | - | - | - | - | 1件: 288 288 |
748 | Mipomersen | 1件: Mipomersen Mipomersen | - | - | - | 1件: 79 79 |
749 | Mirabegron | 1件: Mirabegron Mirabegron | 1件: D09535
D09535
| 1件: ADRB3 ADRB3 💬 | 8件: Calcium signaling pathway Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 13, 53, 226 |
750 | Mirapex | - | - | - | - | 1件: 6 6 |
751 | Mirapex (pramipexole) | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
752 | Mirapex ER | - | - | - | - | 1件: 6 6 |
753 | Mirapex LA | - | - | - | - | 1件: 6 6 |
754 | Mirapexin | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
755 | Mirapexin / Sifrol | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
756 | Mirapexin extended release various strengths | 2件: Manganese citrate Manganese citrate, Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
757 | MIRAPEXIN*30CPR 0,7MG | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
758 | Mirapexin/Sifrol | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
759 | Mirdametinib (MEK Inhibitor) | - | - | - | - | 1件: 34 34 |
760 | Mirdametinib (PD-0325901) oral capsule or dispersible tablet | 1件: PD-0325901 PD-0325901 | - | - | - | 1件: 34 34 |
761 | Miridesap | 1件: Miridesap Miridesap | 1件: D11464
D11464
| 1件: APCS APCS 💬 | - | 1件: 28 28 |
762 | Mirikizumab | 1件: Mirikizumab Mirikizumab | 1件: D11123
D11123
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 37 37, 96, 97 |
763 | Mirikizumab IV | 1件: Mirikizumab Mirikizumab | 1件: D11123
D11123
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 |
764 | Mirikizumab SC | 1件: Mirikizumab Mirikizumab | 1件: D11123
D11123
| 1件: IL23A IL23A 💬 | 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 97 97 |
765 | Mirogabalin | 1件: Mirogabalin Mirogabalin | 1件: D11203
D11203
| 2件: CACNA2D1 CACNA2D1, CACNA2D2 💬 | 7件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | 1件: 70 70 |
766 | MIS416 | - | - | - | - | 1件: 13 13 |
767 | Misoprostol | 1件: Misoprostol Misoprostol | 1件: D00419
D00419
| 3件: PTGER2 PTGER2, PTGER3, PTGER4 💬 | 9件: Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways in cancer, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway 💬 | 3件: 46 46, 70, 271 |
768 | Mitomycin | 1件: Mitomycin Mitomycin | 1件: D00208
D00208
| - | - | 2件: 94 94, 329 |
769 | Mitomycin C | 1件: Mitomycin Mitomycin | 1件: D00208
D00208
| - | - | 1件: 94 94 |
770 | MitoQ | - | - | - | - | 3件: 6 6, 13, 97 |
771 | Mitoquinone | 1件: Mitoquinone Mitoquinone | - | - | - | 1件: 13 13 |
772 | Mitoxantrone | 1件: Mitoxantrone Mitoxantrone | 2件: D02166
D02166
,
D08224
| 2件: TOP2A TOP2A, TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 1件: 13 13 |
773 | Mitral regurgitation SE | - | - | - | - | 3件: 58 58, 86, 215 |
774 | Mizoribine | 1件: Mizoribine Mizoribine | 1件: D01392
D01392
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 8件: 46 46, 49, 51, 53, 66, 94, 222, 224 |
775 | MK-0653 | - | - | - | - | 1件: 260 260 |
776 | MK-0663 | - | - | - | - | 2件: 46 46, 271 |
777 | MK-0859 | - | - | - | - | 1件: 79 79 |
778 | MK-0873 | 1件: MK-0873 MK-0873 | - | - | - | 1件: 46 46 |
779 | MK-3222 | - | - | - | - | 1件: 271 271 |
780 | MK-4836 | - | - | - | - | 1件: 86 86 |
781 | MK-5475 | - | - | - | - | 1件: 86 86 |
782 | MK-6194 | - | - | - | - | 1件: 97 97 |
783 | MK-8259 | - | - | - | - | 1件: 97 97 |
784 | MK-8457 | - | - | - | - | 1件: 46 46 |
785 | MK-8457 (free acid) | - | - | - | - | 1件: 46 46 |
786 | MK-8457 100 mg | - | - | - | - | 1件: 46 46 |
787 | MK-8808 | - | - | - | - | 1件: 46 46 |
788 | MK-8892 | - | - | - | - | 1件: 86 86 |
789 | MK0359 | - | - | - | - | 1件: 46 46 |
790 | MK0653, ezetimibe | 1件: Ezetimibe Ezetimibe | 1件: D01966
D01966
| 1件: NPC1L1 NPC1L1 💬 | 1件: Fat digestion and absorption Fat digestion and absorption 💬 | 1件: 260 260 |
791 | MK0657 | - | - | - | - | 1件: 6 6 |
792 | MK0663, etoricoxib | 1件: Etoricoxib Etoricoxib | 1件: D03710
D03710
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 |
793 | MK0812 | - | - | - | - | 2件: 13 13, 46 |
794 | MK0812 / Duration of Treatment: 12 Weeks | - | - | - | - | 1件: 46 46 |
795 | MK0966 | - | - | - | - | 1件: 46 46 |
796 | MK8457 | - | - | - | - | 1件: 46 46 |
797 | MLN0002 | - | - | - | - | 3件: 94 94, 96, 97 |
798 | MLN0002 (Vedolizumab) | 1件: Vedolizumab Vedolizumab | 1件: D08083
D08083
| 2件: ITGA4 ITGA4, ITGB7 💬 | 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 |
799 | MLN0002 SC | - | - | - | - | 2件: 96 96, 97 |
800 | MLN002 | - | - | - | - | 2件: 96 96, 97 |
801 | MLN1202 | - | - | - | - | 1件: 13 13 |
802 | MLN3897 | - | - | - | - | 1件: 46 46 |
803 | MLTA3698A | 1件: Pateclizumab Pateclizumab | 1件: D10187
D10187
| 1件: LTA LTA 💬 | 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 |
804 | MM-093 | 1件: MM-093 MM-093 | - | - | - | 1件: 46 46 |
805 | MMC | - | - | - | - | 1件: 118 118 |
806 | MMF | - | - | - | - | 15件: 13 13, 35, 40, 46, 49, 50, 51, 60, 65, 66, 162, 222, 224, 226, 299 |
807 | MMF and Dexamethasone | 1件: Dexamethasone Dexamethasone | 9件: D00292
D00292
,
D00975
,
D01510
,
D01615
,
D01632
,
D01948
,
D02174
,
D02591
,
D02592
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 222 222 |
808 | MMX Mesalamine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
809 | MMX mesalamine/ mesalazine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
810 | MMX Mesalamine/Mesalazine | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
811 | MMX Mesalamine/Mesalazine (High Dose) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
812 | MMX Mesalamine/Mesalazine (Low Dose) | 1件: Mesalazine Mesalazine | 1件: D00377
D00377
| - | - | 1件: 97 97 |
813 | MN-001 | - | - | - | - | 1件: 226 226 |
814 | MN-001 BID | - | - | - | - | 1件: 226 226 |
815 | MN-166 | - | - | - | - | 1件: 2 2 |
816 | MNC (Mononuclear cells) | - | - | - | - | 1件: 2 2 |
817 | MNK-1411 | - | - | - | - | 1件: 113 113 |
818 | Mobilization of stem cells to prepare for Leukapheresis | - | - | - | - | 1件: 96 96 |
819 | MOCLOBEMIDE | 1件: Moclobemide Moclobemide | 1件: D02561
D02561
| 1件: MAOA MAOA 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
820 | MOD-4023 | - | - | - | - | 1件: 78 78 |
821 | MODAFINIL | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 4件: 6 6, 13, 49, 93 |
822 | Modafinil 50mg | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 1件: 6 6 |
823 | Modal | - | - | - | - | 5件: 2 2, 6, 17, 46, 70 |
824 | Moderate doses of Thiamine y Biotin | 2件: Biotin Biotin, Thiamine | 2件: D00029
D00029
,
D08580
| - | - | 1件: 8 8 |
825 | Moderate Oligosaccharide Group | - | - | - | - | 1件: 96 96 |
826 | Moderna COVID-19 Vaccine | 1件: Moderna COVID-19 Vaccine Moderna COVID-19 Vaccine | 1件: D12114
D12114
| - | - | 1件: 46 46 |
827 | Moderna mRNA-1273 | - | - | - | - | 5件: 13 13, 35, 46, 49, 51 |
828 | Modified Atkins diet | - | - | - | - | 3件: 145 145, 157, 187 |
829 | Modified cobratoxin | - | - | - | - | 1件: 20 20 |
830 | Modified Gegen Qinlian Decoction | - | - | - | - | 1件: 97 97 |
831 | Modified lipid formulation | - | - | - | - | 1件: 299 299 |
832 | Modified Oral Glucose Tolerance Test (50g 4-hours) | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 1件: 299 299 |
833 | Modified recombinant human c-type | - | - | - | - | 1件: 276 276 |
834 | Modified recombinant human C-type natriuretic peptide | - | - | - | - | 1件: 276 276 |
835 | MODIFIED RHCNP | - | - | - | - | 1件: 276 276 |
836 | Modified-release phosphatidylcholine | 2件: Lecithin Lecithin, Manganese citrate | 1件: D04682
D04682
| - | - | 1件: 97 97 |
837 | Modified-thoracolumbar interfascial plane block | - | - | - | - | 1件: 70 70 |
838 | Modiodal | - | - | - | - | 1件: 6 6 |
839 | MODOPAR | - | - | - | - | 1件: 6 6 |
840 | Modopar 125 | - | - | - | - | 1件: 6 6 |
841 | Modopar 62,5 | - | - | - | - | 1件: 6 6 |
842 | Modulen | - | - | - | - | 1件: 96 96 |
843 | MODULEN IBD | - | - | - | - | 1件: 96 96 |
844 | MODULEN IBD (R) (specific Enteral Nutrition) | - | - | - | - | 1件: 96 96 |
845 | Moexipril | 1件: Moexipril Moexipril | 2件: D00623
D00623
,
D08225
| 1件: ACE ACE 💬 | 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 1件: 93 93 |
846 | MOG peptide | - | - | - | - | 1件: 13 13 |
847 | Mogamulizumab | 1件: Mogamulizumab Mogamulizumab | 1件: D09761
D09761
| 1件: CCR4 CCR4 💬 | 5件: Chemokine signaling pathway Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Kaposi sarcoma-associated herpesvirus infection, Viral carcinogenesis, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 26 26 |
848 | Molgramostim | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 3件: 97 97, 229, 299 |
849 | Molgramostim 300 mcg nebuliser solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
850 | Molgramostim 300 µg nebulizer solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
851 | Molgramostim Nebuliser solution 300 mcg | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 229 229 |
852 | Molgramostim nebulizer solution | 1件: Molgramostim Molgramostim | 1件: D05066
D05066
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 1件: 299 299 |
853 | MOLI 1901 | - | - | - | - | 1件: 299 299 |
854 | Moli 1901 (2622U90, duramycin) | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
855 | Moli1901 | - | - | - | - | 1件: 299 299 |
856 | Moli1901 (2622U90, duramycin) | 1件: Lancovutide Lancovutide | - | - | - | 1件: 299 299 |
857 | Mometasone | 1件: Mometasone Mometasone | 3件: D00690
D00690
,
D03325
,
D08227
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 162 |
858 | MOMETASONE FUROATE | 2件: Mometasone Mometasone, Mometasone furoate | 3件: D00690
D00690
,
D03325
,
D08227
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 98 98, 162 |
859 | MONARSEN | - | - | - | - | 1件: 11 11 |
860 | Mongersen | 1件: Mongersen Mongersen | 1件: D10956
D10956
| 1件: SMAD7 SMAD7 💬 | 2件: Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | 2件: 96 96, 97 |
861 | MONITOR | 1件: Methamidophos Methamidophos | - | - | - | 20件: 2 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300 |
862 | Mono Nuclear Cell (MNC) transplantation | - | - | - | - | 1件: 57 57 |
863 | Mono-Therapy with Sildenafil | 1件: Sildenafil Sildenafil | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 |
864 | Monoamine oxidase B inhibitors | - | - | - | - | 1件: 6 6 |
865 | Monoclonal antibodies | - | - | - | - | 1件: 96 96 |
866 | Monoclonal Antibody (MAb) | - | - | - | - | 1件: 271 271 |
867 | Monoclonal antibody (Mab) sB24M | - | - | - | - | 1件: 269 269 |
868 | MONOCLONAL ANTIBODY ANTI-IGG1 | - | - | - | - | 3件: 37 37, 96, 97 |
869 | Monoclonal antibody cA2 | - | - | - | - | 1件: 96 96 |
870 | Monoclonal antibody M-T412 | - | - | - | - | 1件: 13 13 |
871 | MONOCOR | - | - | - | - | 1件: 67 67 |
872 | Monocytes and megacaryocytes culture and RNA extraction | - | - | - | - | 1件: 113 113 |
873 | Monohydrate | - | - | - | - | 1件: 107 107 |
874 | Monolaurin | 1件: Glyceryl laurate Glyceryl laurate | - | - | - | 1件: 160 160 |
875 | Monolaurin cream | 1件: Glyceryl laurate Glyceryl laurate | - | - | - | 1件: 160 160 |
876 | Monomethyl fumarate | 1件: Monomethyl fumarate Monomethyl fumarate | 1件: D11492
D11492
| - | - | 1件: 13 13 |
877 | Monomethyl fumarate 190 mg | 1件: Monomethyl fumarate Monomethyl fumarate | 1件: D11492
D11492
| - | - | 1件: 13 13 |
878 | Monores | - | - | - | - | 1件: 1 1 |
879 | MONORES*30CPR 20MCG | - | - | - | - | 1件: 1 1 |
880 | Monotherapy (Lopinavir/ritonavir) | 2件: Lopinavir Lopinavir, Ritonavir | 2件: D00427
D00427
,
D01425
| - | - | 1件: 265 265 |
881 | Monotherapy (Lopinavir/ritonavir) + ABC/3TC | 2件: Lopinavir Lopinavir, Ritonavir | 2件: D00427
D00427
,
D01425
| - | - | 1件: 265 265 |
882 | Montelukast | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 8件: 6 6, 13, 46, 61, 63, 85, 98, 228 |
883 | Montelukast Krka | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
884 | MONTELUKAST SODIUM | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 228 228 |
885 | Montelukast Teva | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 228 228 |
886 | Montelukast, Flurbiprofen, Midazolam, Digoxin, Pravastatin and BMS-986142 | 6件: BMS-986142 BMS-986142, Digoxin, Flurbiprofen, Midazolam, Montelukast, Pravastatin | 11件: D00298
D00298
,
D00330
,
D00529
,
D00550
,
D00696
,
D00893
,
D01475
,
D02290
,
D05028
,
D08229
,
D08410
| 24件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4, CYSLTR1, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HMGCR, PTGS1, PTGS2 💬 | 49件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Arachidonic acid metabolism, Bile secretion, C-type lectin receptor signaling pathway, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Endocrine and other factor-regulated calcium reabsorption, GABAergic synapse, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Insulin secretion, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Mineral absorption, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pancreatic secretion, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, Taste transduction, Terpenoid backbone biosynthesis, Thyroid hormone signaling pathway, Thyroid hormone synthesis, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 46 46 |
887 | Montelukast/ Singulair | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 98 98 |
888 | Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 2 2 |
889 | MOR03087 | - | - | - | - | 2件: 66 66, 222 |
890 | MOR103 | - | - | - | - | 2件: 13 13, 46 |
891 | MOR202 | - | - | - | - | 2件: 66 66, 222 |
892 | MORAb-022 | - | - | - | - | 1件: 46 46 |
893 | Morphine | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 6件: 36 36, 46, 70, 85, 86, 298 |
894 | Morphine Hexal | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
895 | Morphine hydrochloride | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 85 85 |
896 | Morphine PCA | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
897 | MORPHINE SULFATE | 2件: Morphine Morphine, Sulfate ion | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 3件: 46 46, 85, 86 |
898 | Morphine sulphate in intrasite gel | 1件: Morphine Morphine | 3件: D00842
D00842
,
D02271
,
D08233
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 36 36 |
899 | Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics) | 4件: Buprenorphine Buprenorphine, Meperidine, Metamizole, Morphine | 8件: D00836
D00836
,
D00842
,
D01383
,
D02271
,
D07132
,
D08188
,
D08233
,
D08343
| 2件: OPRK1 OPRK1, OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 298 298 |
900 | Morphinsulfat | - | - | - | - | 1件: 46 46 |
901 | Mosapride | 1件: Mosapride Mosapride | 1件: D08236
D08236
| 1件: HTR4 HTR4 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 96 96 |
902 | Moss-aGal (recombinant human alpha-galactosidase A produced in moss) | 1件: Agalsidase alfa Agalsidase alfa | 1件: D02784
D02784
| 1件: GLA GLA 💬 | 6件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Metabolic pathways, Sphingolipid metabolism 💬 | 1件: 19 19 |
903 | Most recent vaccine to seasonal influenza | - | - | - | - | 1件: 13 13 |
904 | Mosunetuzumab | 1件: Mosunetuzumab Mosunetuzumab | 1件: D11463
D11463
| 2件: CD3E CD3E, MS4A1 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 49 49 |
905 | MOTILIUM | - | - | - | - | 2件: 6 6, 230 |
906 | Motion Analysis | - | - | - | - | 1件: 6 6 |
907 | Movprep | - | - | - | - | 1件: 96 96 |
908 | Moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 9件: 2 2, 6, 46, 49, 85, 86, 113, 240, 299 |
909 | Moxifloxacin 400 mg | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 1件: 86 86 |
910 | Moxifloxacin Hydrochloride | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 2件: 113 113, 299 |
911 | Moxifloxacin infusion | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 1件: 6 6 |
912 | Mozobil | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 19 19, 65, 285 |
913 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - F | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 19 19 |
914 | MOZOBIL - 20 MG/ML - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - FLACONCINO (VETRO) - 24 MG/1.2 ML 1 FLACONCINO | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 65 65 |
915 | Mozobil 20mg/mL vial (injectable solution for subcutaneous use) | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 65 65 |
916 | Mozobil 20mg/mL vial (injectable solution, subcutaneous use) | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 65 65 |
917 | Mozobil, | 1件: Plerixafor Plerixafor | 1件: D08971
D08971
| 1件: CXCR4 CXCR4 💬 | 12件: Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 65 65 |
918 | MP and CTX | - | - | - | - | 1件: 222 222 |
919 | MP-376 | - | - | - | - | 1件: 299 299 |
920 | MP-376 (Levofloxacin Solution for Inhalation) | 1件: Levofloxacin Levofloxacin | 2件: D00588
D00588
,
D08120
| - | - | 1件: 299 299 |
921 | MP-435(dose1) + Methotrexate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 46 46 |
922 | MPA | - | - | - | - | 6件: 13 13, 35, 46, 49, 51, 60 |
923 | MPC | - | - | - | - | 2件: 210 210, 211 |
924 | MPH966 | - | - | - | - | 2件: 228 228, 231 |
925 | MPS | - | - | - | - | 1件: 19 19 |
926 | MQX-503 | - | - | - | - | 1件: 51 51 |
927 | MR Prednisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 46 46 |
928 | MR-MC-01 | - | - | - | - | 1件: 226 226 |
929 | MRA | - | - | - | - | 2件: 46 46, 107 |
930 | MRA (Actemra) | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 107 107 |
931 | MRA (Tocilizumab) | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 |
932 | MRA 003 US | - | - | - | - | 1件: 49 49 |
933 | MRA(Tocilizumab) | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 |
934 | MRA, Actemra | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 |
935 | MRA-SC | - | - | - | - | 1件: 46 46 |
936 | MRC375 | - | - | - | - | 1件: 46 46 |
937 | MRC375 150mg | - | - | - | - | 1件: 46 46 |
938 | MRI | - | - | - | - | 5件: 13 13, 70, 78, 85, 278 |
939 | MRI contrast-enhancing preparations | - | - | - | - | 1件: 13 13 |
940 | MRI Imaging with intravenous contrast with gadoterate meglumine | 2件: Gadoteric acid Gadoteric acid, Meglumine | 2件: D01796
D01796
,
D08007
| - | - | 1件: 53 53 |
941 | MRI with contrast agent injection | - | - | - | - | 1件: 19 19 |
942 | MRI with PFP | - | - | - | - | 1件: 299 299 |
943 | MRI without contrast agent injection | - | - | - | - | 1件: 19 19 |
944 | MRI, FDG-PET/CT scans | - | - | - | - | 1件: 34 34 |
945 | MRI, Venipuncture | - | - | - | - | 1件: 49 49 |
946 | MRNA che codifica l’enzima umano deramificante del glicogeno formulato in una nanopaticella lipidica | - | - | - | - | 1件: 257 257 |
947 | MRNA COVD19 vaccine | - | - | - | - | 3件: 49 49, 53, 271 |
948 | MRNA COVID-19 vaccine | - | - | - | - | 1件: 13 13 |
949 | MRNA encoding modified Ornithine transcarbamylase | 1件: Ornithine Ornithine | 1件: D08302
D08302
| - | - | 1件: 251 251 |
950 | MRNA encoding the human glycogen debranching enzyme | - | - | - | - | 1件: 257 257 |
951 | MRNA encoding the human glycogen debranching enzyme formulated in a lipid nanoparticle delivery | - | - | - | - | 1件: 257 257 |
952 | MRNA-3704 | - | - | - | - | 1件: 246 246 |
953 | MRNA-3705 | - | - | - | - | 1件: 246 246 |
954 | MRNA-3927 | - | - | - | - | 1件: 245 245 |
955 | MRT5005 | - | - | - | - | 1件: 299 299 |
956 | MRT5201 | - | - | - | - | 1件: 251 251 |
957 | MRX Drug Substance (formerly Maralixibat , SHP625 or LUM001) | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 1件: 338 338 |
958 | MRX Drug Substance (formerly Maralixibat, SHP625 or LUM001) | 1件: Maralixibat Maralixibat | 1件: D10951
D10951
| 2件: SLC10A1 SLC10A1, SLC10A2 💬 | 2件: Bile secretion Bile secretion, Hepatitis B 💬 | 1件: 338 338 |
959 | MS Band 2 | - | - | - | - | 1件: 6 6 |
960 | MS-20 oral solution | - | - | - | - | 1件: 97 97 |
961 | MS1819 | - | - | - | - | 2件: 298 298, 299 |
962 | MS1819-SD | 1件: MS-1819 MS-1819 | - | - | - | 2件: 298 298, 299 |
963 | MSB11022 | - | - | - | - | 1件: 46 46 |
964 | MSB11456 | - | - | - | - | 1件: 46 46 |
965 | MSC | - | - | - | - | 6件: 6 6, 51, 60, 96, 97, 271 |
966 | MSC injection 01 | - | - | - | - | 1件: 96 96 |
967 | MSC injection 02 | - | - | - | - | 1件: 96 96 |
968 | MSC treatment | - | - | - | - | 1件: 49 49 |
969 | MSC treatment 01 | - | - | - | - | 1件: 96 96 |
970 | MSC treatment 02 | - | - | - | - | 1件: 96 96 |
971 | MSC+ATG | - | - | - | - | 1件: 60 60 |
972 | MSC-AFP | - | - | - | - | 1件: 96 96 |
973 | MSC-NTF cells transplantation (IM) | - | - | - | - | 1件: 2 2 |
974 | MSC-NTF cells transplantation (IT) | - | - | - | - | 1件: 2 2 |
975 | MSC2015 | - | - | - | - | 1件: 13 13 |
976 | MSC2304479A | - | - | - | - | 1件: 13 13 |
977 | MSC2304480A | - | - | - | - | 1件: 13 13 |
978 | MSC2304481A | - | - | - | - | 1件: 13 13 |
979 | MSC2304482A | - | - | - | - | 1件: 13 13 |
980 | MSC2358825A | - | - | - | - | 1件: 13 13 |
981 | MSC2364447C | - | - | - | - | 2件: 13 13, 49 |
982 | MSC2430913A or ONO-4641 (to be used as synonyms) | - | - | - | - | 1件: 13 13 |
983 | MSC2491529A | - | - | - | - | 1件: 13 13 |
984 | MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF | - | - | - | - | 1件: 2 2 |
985 | MSCs | - | - | - | - | 1件: 228 228 |
986 | MSDMDs other than Betaseron (Interferon beta-1b, BAY86-5046) | 2件: Human interferon beta Human interferon beta, Interferon beta-1b | 1件: D00746
D00746
| 2件: IFNAR1 IFNAR1, IFNAR2 💬 | 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 |
987 | MSI-1995 | - | - | - | - | 1件: 299 299 |
988 | MSK-DA01 | - | - | - | - | 1件: 6 6 |
989 | MSK-DA01 Cell Delivery Device | - | - | - | - | 1件: 6 6 |
990 | MSmonitor, a self-management/education program with e-health interventions | - | - | - | - | 1件: 13 13 |
991 | MSTC-001 (MS-STAT) | - | - | - | - | 1件: 13 13 |
992 | MT-1186 | - | - | - | - | 1件: 2 2 |
993 | MT-1303 | - | - | - | - | 3件: 13 13, 96, 97 |
994 | MT-1303 [0.1] | - | - | - | - | 1件: 13 13 |
995 | MT-1303 [0.2] | - | - | - | - | 1件: 13 13 |
996 | MT-1303 [0.4] | - | - | - | - | 1件: 13 13 |
997 | MT-1303 High dose | - | - | - | - | 1件: 49 49 |
998 | MT-1303 Low dose | - | - | - | - | 1件: 49 49 |
999 | MT-1303-FormA | - | - | - | - | 1件: 13 13 |
1000 | MT-1303-FormB | - | - | - | - | 1件: 13 13 |
1001 | MT-1303-High | - | - | - | - | 1件: 13 13 |
1002 | MT-1303-Low | - | - | - | - | 1件: 13 13 |
1003 | MT-1303-Middle | - | - | - | - | 1件: 13 13 |
1004 | MT-3921 | - | - | - | - | 1件: 26 26 |
1005 | MT-7117 | - | - | - | - | 2件: 51 51, 254 |
1006 | MT-7117 High Dose | - | - | - | - | 1件: 254 254 |
1007 | MT-7117 Low Dose | - | - | - | - | 1件: 254 254 |
1008 | MT203 | 1件: Namilumab Namilumab | - | - | - | 1件: 46 46 |
1009 | MTC TRx0014-001 capsules | - | - | - | - | 1件: 127 127 |
1010 | MTP-131 | - | - | - | - | 1件: 21 21 |
1011 | MTRX1011A | - | - | - | - | 1件: 46 46 |
1012 | MTT | - | - | - | - | 1件: 299 299 |
1013 | MTX | - | - | - | - | 14件: 13 13, 35, 40, 46, 49, 50, 51, 60, 84, 96, 97, 107, 162, 271 |
1014 | MTX 12.5 | - | - | - | - | 1件: 97 97 |
1015 | MTX 25 | - | - | - | - | 1件: 97 97 |
1016 | MTX Goldshield Tablets | - | - | - | - | 1件: 46 46 |
1017 | MTX HEXAL 2,5 mg Tabletten | - | - | - | - | 1件: 46 46 |
1018 | MTX HEXAL 2,5mg Tabletten | - | - | - | - | 1件: 46 46 |
1019 | MTX HEXAL Tablets | - | - | - | - | 1件: 46 46 |
1020 | MTX plus anti-TNF | - | - | - | - | 1件: 46 46 |
1021 | MTX start | - | - | - | - | 1件: 46 46 |
1022 | MTX therapy | - | - | - | - | 1件: 46 46 |
1023 | Mucoid exopolysaccharide P. aeruginosa immune globulin IV | - | - | - | - | 1件: 299 299 |
1024 | Mucolysin | - | - | - | - | 1件: 299 299 |
1025 | Mucomyst | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 299 299 |
1026 | Mucosta | - | - | - | - | 1件: 53 53 |
1027 | Multi-glycoside of Tripterygium Wilfordii HOOK. f. (TWH) | 1件: Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | 1件: 66 66 |
1028 | Multi-modal pain management [Acetaminophen + Gabapentin] | 2件: Acetaminophen Acetaminophen, Gabapentin | 2件: D00217
D00217
,
D00332
| 7件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 | 31件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis - DNA adducts, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 70 70 |
1029 | Multi-modal pain management [Fentanyl] | 1件: Fentanyl Fentanyl | 2件: D00320
D00320
,
D01399
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 70 70 |
1030 | Multi-modal pain management [Intravenous Ketamine] | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 70 70 |
1031 | Multi-modal pain management [Valium + Gabapentin] | 1件: Gabapentin Gabapentin | 1件: D00332
D00332
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 70 70 |
1032 | Multienzymes (lipase, protease etc.) | - | - | - | - | 2件: 298 298, 299 |
1033 | Multiferon | - | - | - | - | 1件: 13 13 |
1034 | Multigrain powder (S) | - | - | - | - | 1件: 46 46 |
1035 | MultiHance | 1件: Gadobenic acid Gadobenic acid | 2件: D04283
D04283
,
D08018
| - | - | 2件: 86 86, 88 |
1036 | Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) | - | - | - | - | 1件: 13 13 |
1037 | Multiple Dose | - | - | - | - | 1件: 2 2 |
1038 | Multiple dose- Group B | - | - | - | - | 1件: 97 97 |
1039 | Multiple dose-Group B | - | - | - | - | 1件: 97 97 |
1040 | MultiSpectral Imaging System | - | - | - | - | 1件: 46 46 |
1041 | MultiStem | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 |
1042 | MultiStem high dose | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 |
1043 | MultiStem low dose | 1件: MultiStem MultiStem | - | - | - | 1件: 97 97 |
1044 | Multivitamin | - | - | - | - | 1件: 49 49 |
1045 | Mupirocin | 1件: Mupirocin Mupirocin | 2件: D01076
D01076
,
D02195
| - | - | 2件: 227 227, 299 |
1046 | Mupirocin Intranasal Creme | 1件: Mupirocin Mupirocin | 2件: D01076
D01076
,
D02195
| - | - | 1件: 299 299 |
1047 | Muromonab | 1件: Muromonab Muromonab | 1件: D05092
D05092
| 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 60 60 |
1048 | Muromonab-CD3 | 1件: Muromonab Muromonab | 1件: D05092
D05092
| 3件: CD3D CD3D, CD3E, CD3G 💬 | 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 60 60 |
1049 | Muscimol | 1件: Muscimol Muscimol | - | - | - | 1件: 6 6 |
1050 | Mushroom | 1件: Cultivated mushroom Cultivated mushroom | - | - | - | 1件: 46 46 |
1051 | Mushroom extract | 1件: Cultivated mushroom Cultivated mushroom | - | - | - | 1件: 46 46 |
1052 | Mussel oil capsules | - | - | - | - | 1件: 46 46 |
1053 | Mutagrip | - | - | - | - | 2件: 11 11, 13 |
1054 | MVA | - | - | - | - | 1件: 96 96 |
1055 | MVA HAV | - | - | - | - | 1件: 96 96 |
1056 | MXB-8025 | - | - | - | - | 1件: 93 93 |
1057 | Myalept | 1件: Metreleptin Metreleptin | 1件: D05014
D05014
| 1件: LEPR LEPR 💬 | 6件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬 | 1件: 265 265 |
1058 | MyBETAapp | - | - | - | - | 1件: 13 13 |
1059 | Mycodigest supplement | - | - | - | - | 2件: 96 96, 97 |
1060 | Mycofenolate Mofetil (MMF) | - | - | - | - | 1件: 226 226 |
1061 | Mycophenolat-Natrium | - | - | - | - | 1件: 66 66 |
1062 | Mycophenolate | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
1063 | Mycophenolate mofeti | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 95 95 |
1064 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
1065 | Mycophenolate mofetil (CellCept) | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 11 11, 13 |
1066 | Mycophenolate mofetil (MMF) | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 7件: 13 13, 49, 51, 60, 65, 66, 222 |
1067 | Mycophenolate Mofetil (MMF) 3 g/Day | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 35 35 |
1068 | Mycophenolate Mofetil 2 g/Day | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 35 35 |
1069 | Mycophenolate mofetil 2000mg/d | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 53 53 |
1070 | Mycophenolate Mofetil 500mg | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 3件: 49 49, 51, 61 |
1071 | Mycophenolate mofetil [CellCept] | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 11 11 |
1072 | Mycophenolate mofetil orally 1000 mg twice a day (BID) | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 222 222 |
1073 | Mycophenolate mofetil plus lower dose of Prednisone | 3件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid, Prednisone | 5件: D00473
D00473
,
D00752
,
D05094
,
D05095
,
D05096
| 3件: IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | 1件: 66 66 |
1074 | Mycophenolate mofetil TEVA | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 53 53 |
1075 | Mycophenolate mofetil(MMF) | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 224 224 |
1076 | Mycophenolate mofetil, low dose steroid | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 222 222 |
1077 | Mycophenolate mofetil,methotrexate | 3件: Methotrexate Methotrexate, Mycophenolate mofetil, Mycophenolic acid | 6件: D00142
D00142
,
D00752
,
D02115
,
D05094
,
D05095
,
D05096
| 4件: DHFR DHFR, DHFR2, IMPDH1, IMPDH2 💬 | 7件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Drug metabolism - other enzymes, Folate biosynthesis, Metabolic pathways, One carbon pool by folate, Purine metabolism 💬 | 3件: 42 42, 43, 45 |
1078 | Mycophenolate motetil | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 49 49 |
1079 | Mycophenolate sodium | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 3件: 53 53, 66, 222 |
1080 | Mycophenolic acid | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 8件: 11 11, 43, 49, 51, 60, 66, 96, 222 |
1081 | Mycophenolic acid mofetil | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 60 60 |
1082 | Mycophenolic sodium | - | - | - | - | 2件: 66 66, 222 |
1083 | Mycophenylate mofetil | - | - | - | - | 2件: 19 19, 20 |
1084 | Mycophénolate mofétil | - | - | - | - | 1件: 44 44 |
1085 | Myeloablative conditioning regimen | - | - | - | - | 1件: 164 164 |
1086 | Myeloablative Conditioning-Closed with amendment L | - | - | - | - | 1件: 65 65 |
1087 | Myeloablative Preparative Regimen | - | - | - | - | 3件: 62 62, 65, 284 |
1088 | MYELOSTIM | - | - | - | - | 1件: 65 65 |
1089 | MYELOSTIM - 34 1 FLACONCINO LIOFILIZZATO 33.6 MIU + SIRINGA PRERIEMPITA SOLVENTE 1 ML | - | - | - | - | 2件: 19 19, 65 |
1090 | MYELOSTIM 34 milions UI/ml - powder and solvent for solution for injection/infusion | - | - | - | - | 1件: 65 65 |
1091 | MYELOSTIM 34 milions UI/ml, powder and solvent for solution for injection or infusion | - | - | - | - | 1件: 65 65 |
1092 | MYELOSTIM 34*1FL 263MCG+1SIR | - | - | - | - | 1件: 2 2 |
1093 | Myfortic | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 5件: 49 49, 66, 162, 222, 228 |
1094 | Myfortic 180 mg | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 162 162 |
1095 | Myfortic 180 mg Filmtabletten | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 162 162 |
1096 | Myfortic 180mg Tablets | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 66 66, 222 |
1097 | Myfortic 360mg Tablets | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 2件: 66 66, 222 |
1098 | Myfortic plus low-dose steroid | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 222 222 |
1099 | MYFORTIC*50CPR RIV 360MG | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 1件: 49 49 |
1100 | MYK-461 | - | - | - | - | 1件: 58 58 |
1101 | MYO-029 | 1件: MYO-029 MYO-029 | - | - | - | 1件: 113 113 |
1102 | Myoblast autologous graft | - | - | - | - | 1件: 113 113 |
1103 | Myoblast transplantation | - | - | - | - | 1件: 113 113 |
1104 | Myoblastes autologues | - | - | - | - | 1件: 113 113 |
1105 | MYODM | - | - | - | - | 1件: 113 113 |
1106 | Myonal | - | - | - | - | 1件: 2 2 |
1107 | MYONAL*30CPR RIV 100MG | - | - | - | - | 1件: 2 2 |
1108 | Myozyme | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1109 | Myozyme 50 mg powder for concentrate for solution for infusion | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1110 | MYOZYME® | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1111 | Myozyme® (alglucosidase alfa) | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: D03207
D03207
| 1件: GAA GAA 💬 | 4件: Galactose metabolism Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬 | 1件: 256 256 |
1112 | MYRRH | 1件: Myrrh Myrrh | 1件: D08948
D08948
| - | - | 1件: 97 97 |
1113 | Myrrhinil-Intest® | - | - | - | - | 1件: 97 97 |
1114 | Mysildecard | - | - | - | - | 1件: 210 210 |
1115 | MZ101 | - | - | - | - | 1件: 210 210 |
1116 | Mémantine | - | - | - | - | 1件: 6 6 |
1117 | Méthotrexate | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 271 271 |
1118 | Méthotrexate Bellon Comprimé | 1件: Methotrexate Methotrexate | 2件: D00142
D00142
,
D02115
| 2件: DHFR DHFR, DHFR2 💬 | 5件: Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | 1件: 271 271 |
1119 | Méthylprednisolone | - | - | - | - | 1件: 13 13 |
1120 | Méthylprednisolone Mylan | - | - | - | - | 1件: 13 13 |